https://curecurrent.com/trials/liposomal-doxorubicin-lipo-dox-in-patients-with-brain-metastasis-from-breast-cancer-41001https://curecurrent.com/trials/genetic-expression-and-prediction-of-response-to-neoadjuvant-docetaxel-or-doxorubicin-in-locally-advanced-breast-cancer-41002https://curecurrent.com/trials/computed-tomography-ct-based-lymphatic-mapping-and-localization-of-sentinel-lymph-node-in-breast-cancer-patients-41003https://curecurrent.com/trials/phase-i-study-of-aprotinin-in-advanced-breast-cancer-41004https://curecurrent.com/trials/randomized-trial-of-follow-up-strategies-in-breast-cancer-41005https://curecurrent.com/trials/genetic-studies-in-breast-cancer-41006https://curecurrent.com/trials/study-evaluating-the-pharmacokinetics-pk-and-safety-of-bosutinib-in-subjects-with-liver-disease-and-in-healthy-subjects-41007https://curecurrent.com/trials/passion-p-trial-ph-adjusted-sulfur-colloid-sentinel-initiative-on-pain-trial-41008https://curecurrent.com/trials/comparison-of-laryngeal-mask-airway-lma-and-tracheal-tube-in-modified-radical-mastectomy-on-breast-cancer-41009https://curecurrent.com/trials/comparing-local-anesthesia-with-general-anesthesia-for-breast-cancer-surgery-41010https://curecurrent.com/trials/adherence-to-intensive-surveillance-for-hereditary-breast-cancer-41011https://curecurrent.com/trials/orthostatic-tolerance-in-mamma-cancer-patients-after-anaesthesia-41012https://curecurrent.com/trials/pilot-study-to-evaluate-high-resolution-pet-image-guidance-for-sampling-of-breast-abnormalities-41013https://curecurrent.com/trials/an-open-label-non-interventional-evaluation-of-the-effect-of-adjuvant-hormonal-treatment-of-postmenopausal-women-wih-ear-41014https://curecurrent.com/trials/efficacy-study-of-single-agent-trastuzumab-or-lapatinib-to-treat-her2-overexpressing-breast-cancer-41015https://curecurrent.com/trials/cyclophosphamide-methotrexate-and-prednisolone-with-or-without-aromatase-inhibitor-therapy-in-treating-postmenopausal-wo-41016https://curecurrent.com/trials/cyclophosphamide-and-docetaxel-or-doxorubicin-in-treating-women-with-newly-diagnosed-breast-cancer-that-can-be-removed-b-41017https://curecurrent.com/trials/efficacy-study-of-gemcitabine-paclitaxel-to-treat-metastatic-breast-cancer-41018https://curecurrent.com/trials/evaluating-the-role-of-the-addition-of-ovarian-function-suppression-ofs-to-tamoxifen-in-young-women-41019https://curecurrent.com/trials/a-clinical-trial-of-paclitaxel-loaded-polymeric-micelle-in-patients-with-taxane-pretreated-recurrent-breast-cancer-41020https://curecurrent.com/trials/exemestane-aromasine-tamoxifen-breast-neo-adjuvant-41021https://curecurrent.com/trials/effectiveness-of-combination-of-arimidex-and-nolvadex-in-adjuvant-therapy-of-breast-carcinoma-in-postmenopausal-women-41022https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-tocosol-r-paclitaxel-as-initial-treatment-for-metastatic-breast-cancer-41023https://curecurrent.com/trials/phase-1-dose-escalation-study-of-sn2310-injectable-emulsion-in-patients-with-advanced-solid-tumors-41024https://curecurrent.com/trials/comparison-of-safety-and-efficacy-of-tocosol-r-paclitaxel-versus-taxol-r-for-treatment-of-metastatic-breast-cancer-41025https://curecurrent.com/trials/to-determine-the-objective-response-rate-of-4-cycles-of-docetaxel-anthracycline-epirubicin-or-doxorubicine-followed-by-4-41026https://curecurrent.com/trials/a-study-to-determine-the-antitumor-activity-and-evaluate-the-safety-of-mkc-1-41027https://curecurrent.com/trials/pemetrexed-as-the-first-treatment-in-advanced-or-metastatic-breast-cancer-41028https://curecurrent.com/trials/randomized-phase-iii-trial-with-docetaxel-plus-epirubicine-versus-docetaxel-plus-capecitabine-for-metastatic-breast-canc-41029https://curecurrent.com/trials/pemetrexed-plus-gemcitabine-in-metastatic-breast-cancer-patients-after-receiving-taxane-therapy-41030https://curecurrent.com/trials/influence-of-fibrin-glue-on-seroma-formation-after-modified-radical-mastectomy-41031https://curecurrent.com/trials/phase-ii-study-with-the-trifunctional-antibody-ertumaxomab-to-treat-metastatic-breast-cancer-progressing-after-endocrine-41032https://curecurrent.com/trials/atac-pharmacokinetics-pk-sub-protocol-41033https://curecurrent.com/trials/study-of-exemestane-after-anastrozole-or-letrozole-treatment-of-postmenopausal-women-with-hormone-responsive-breast-canc-41034https://curecurrent.com/trials/cavilon-breast-trial-comparison-of-cavilon-durable-barrier-cream-to-glycerine-sorbolene-cream-41035https://curecurrent.com/trials/hormone-replacement-therapy-in-relieving-menopausal-symptoms-in-postmenopausal-women-with-previous-stage-i-or-stage-ii-b-41036https://curecurrent.com/trials/chemotherapy-related-anemia-in-patients-with-non-myeloid-malignancies-41037https://curecurrent.com/trials/efficacy-of-snx-1012-in-the-treatment-of-oral-mucositis-41038https://curecurrent.com/trials/intravenous-rpr109881-in-male-or-female-patients-with-advanced-breast-cancer-who-no-longer-respond-to-anthracycline-taxa-41039https://curecurrent.com/trials/atac-endometrial-sub-protocol-41040https://curecurrent.com/trials/ita-clinical-study-comparing-arimidex-with-nolvadex-in-women-with-breast-cancer-treated-with-nolvadex-for-at-least-2-yea-41041https://curecurrent.com/trials/atac-quality-of-life-sub-protocol-41042https://curecurrent.com/trials/3-years-of-anastrozole-vs-no-treatment-as-extended-adjuvant-therapy-for-postmenopausal-women-with-breast-cancer-41043https://curecurrent.com/trials/whole-body-hyperthermia-combined-with-chemotherapy-in-treating-patients-with-metastatic-breast-ovarian-endometrial-or-ce-41044https://curecurrent.com/trials/dose-escalation-trial-of-2-deoxy-d-glucose-2dg-in-subjects-with-advanced-solid-tumors-41045https://curecurrent.com/trials/atac-bone-density-sub-protocol-41046https://curecurrent.com/trials/zd1839-iressa-in-combination-with-docetaxel-as-first-line-treatment-in-patients-with-metastatic-breast-cancer-41047https://curecurrent.com/trials/a-trial-to-evaluate-the-combination-of-iressa-faslodex-in-patients-with-advanced-or-metastatic-breast-cancer-41048https://curecurrent.com/trials/phase-ii-neoadjuvant-er-pgr-arimidex-iressa-study-41049https://curecurrent.com/trials/ph-ii-early-bc-pre-surgical-biologic-study-41050https://curecurrent.com/trials/quality-of-life-while-receiving-faslodex-41051https://curecurrent.com/trials/iressa-gefitinib-in-breast-cancer-patients-41052https://curecurrent.com/trials/faslodex-observations-during-regular-use-by-advanced-mammacarcinoma-patients-41053https://curecurrent.com/trials/second-line-breast-cancer-trial-41054https://curecurrent.com/trials/androgen-therapy-for-breast-cancer-patients-with-aromatase-inhibitor-induced-side-effects-41055https://curecurrent.com/trials/study-of-motexafin-gadolinium-and-docetaxel-for-advanced-cancer-41056https://curecurrent.com/trials/trial-of-myocet-in-metastatic-breast-cancer-41057https://curecurrent.com/trials/131-i-tm-601-study-in-adults-with-solid-tumors-41058https://curecurrent.com/trials/comparison-of-pain-therapeutic-effects-after-benign-mastectomy-41059https://curecurrent.com/trials/phase-3-study-of-acupression-s-bracelets-in-nausea-and-vomiting-induced-by-fec100-chemotherapy-s-sort-41060https://curecurrent.com/trials/markers-for-breast-cancer-41061https://curecurrent.com/trials/pf-3512676-cpg-7909-injection-for-patients-who-completed-an-oncology-study-using-pf-3512676-cpg-7909-41062https://curecurrent.com/trials/effects-of-soy-compounds-on-breast-cancer-prostate-cancer-and-bone-health-41063https://curecurrent.com/trials/cpg-7909-plus-herceptin-in-patients-with-metastatic-breast-cancer-41064https://curecurrent.com/trials/retrospective-survey-of-bone-fracture-in-patients-with-arimidex-1mg-41065https://curecurrent.com/trials/assessment-of-endometrial-changes-in-postmenopausal-women-with-breast-cancer-in-adjuvant-treatment-with-anastrozole-41066https://curecurrent.com/trials/safety-and-immunogenicity-of-chp-her2-and-chp-ny-eso-1-protein-with-ok-432-in-antigen-expressing-cancers-41067https://curecurrent.com/trials/study-of-bone-mineral-density-in-postmenopausal-women-after-treatment-for-breast-cancer-41068https://curecurrent.com/trials/adjuvant-breast-cancer-study-of-the-netherlands-working-party-for-autotransplantation-in-solid-tumors-41069https://curecurrent.com/trials/a-study-of-liposomal-doxorubicin-in-women-with-breast-cancer-exploiting-tissue-doppler-imaging-41070https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-resected-breast-cancer-41071https://curecurrent.com/trials/adjuvant-radiation-therapy-compared-with-observation-after-surgery-in-treating-women-with-estrogen-receptor-positive-or-41072https://curecurrent.com/trials/prolonged-tamoxifen-compared-with-shorter-tamoxifen-in-treating-patients-who-have-breast-cancer-41073https://curecurrent.com/trials/combination-chemotherapy-with-or-without-darbepoetin-alfa-in-treating-women-with-stage-iii-breast-cancer-41074https://curecurrent.com/trials/an-effective-and-compliance-regimen-of-paclitaxel-plus-cisplatin-to-treat-metastatic-breast-cancer-41075https://curecurrent.com/trials/study-in-epcam-positive-patients-with-symptomatic-malignant-ascites-using-removab-versus-an-untreated-control-group-41076https://curecurrent.com/trials/brief-smoking-intervention-for-women-undergoing-breast-cancer-surgery-41077https://curecurrent.com/trials/exploratory-phase-0-study-of-positron-emission-tomography-pet-imaging-agent-f-18-rgd-k5-41078https://curecurrent.com/trials/t3ai-pain-after-breast-surgery-41079https://curecurrent.com/trials/diffusion-weighted-mri-for-lymphnodes-in-the-axilla-41080https://curecurrent.com/trials/study-of-su011248-in-combination-with-paclitaxel-in-patients-with-metastatic-breast-cancer-41081https://curecurrent.com/trials/healing-touch-and-health-related-quality-of-life-in-women-with-breast-cancer-receiving-radiation-therapy-41082https://curecurrent.com/trials/combined-treatment-of-cetuximab-and-paclitaxel-in-basal-like-breast-carcinoma-41083https://curecurrent.com/trials/tesmilifene-in-combination-with-docetaxel-in-the-treatment-of-metastatic-breast-cancer-41084https://curecurrent.com/trials/arimidex-bone-mass-index-and-oral-bisphosphonates-41085https://curecurrent.com/trials/sonographic-visibility-of-breast-biopsy-marker-clips-up-to-4-weeks-after-placement-41086https://curecurrent.com/trials/cyp2d6-genotyping-by-amplichiptm-cyp450-for-tamoxifen-treated-breast-cancer-patients-41087https://curecurrent.com/trials/adjuvant-post-tamoxifen-exemestane-trial-41088https://curecurrent.com/trials/prevention-of-breast-cancer-as-simple-as-hcg-a-randomized-clinical-trial-in-high-risk-women-41089https://curecurrent.com/trials/a-study-of-5-fluorouracil-and-the-anti-tumor-activity-of-adh300004-and-5-fluorouracil-in-subjects-with-incurable-solid-t-41090https://curecurrent.com/trials/investigating-the-impact-of-tailored-reports-on-anxiety-amongst-cancer-patients-and-their-confidants-41091https://curecurrent.com/trials/yoga-to-reduce-cancer-fatigue-41092https://curecurrent.com/trials/a-study-of-su11248-in-patients-with-metastatic-breast-cancer-who-have-failed-selected-other-therapies-41093https://curecurrent.com/trials/a-study-of-gemcitabine-epirubicin-and-paclitaxel-combination-chemotherapy-given-before-surgery-to-patients-with-locally-41094https://curecurrent.com/trials/light-based-analysis-of-developing-breast-tissue-in-adolescent-girls-a-feasibility-study-41095https://curecurrent.com/trials/neoadjuvant-doxorubicin-cyclophosphamide-followed-by-docetaxel-ac-doc-versus-dose-dense-doxorubicin-and-docetaxel-adoc-i-41096https://curecurrent.com/trials/venlafaxine-for-hot-flashes-after-breast-cancer-41097https://curecurrent.com/trials/vinorelbine-and-oxaliplatin-vinox-with-or-without-trastuzumab-herceptin-in-advanced-breast-carcinoma-41098https://curecurrent.com/trials/pv-10-chemoablation-of-recurrent-breast-carcinoma-41099https://curecurrent.com/trials/study-evaluating-ascending-single-dose-of-bosutinib-administered-with-multiple-doses-of-ketoconazole-to-healthy-subjects-41100https://curecurrent.com/trials/phase-ib-ii-trial-combining-vinorelbine-with-sorafenib-as-first-line-treatment-in-patients-with-metastatic-breast-cancer-41101https://curecurrent.com/trials/androgen-therapy-for-management-of-estrogen-progesterone-receptor-negative-er-pr-metastatic-breast-cancer-41102https://curecurrent.com/trials/irinotecan-in-patients-with-advanced-metastatic-breast-cancer-who-have-experienced-failure-of-an-anthracycline-a-taxane-41103https://curecurrent.com/trials/vaccination-against-high-risk-breast-cancer-using-tumor-derived-heat-shock-protein-70-41104https://curecurrent.com/trials/feasibility-study-of-evaluating-breast-cancer-patients-with-ductal-lavage-41105https://curecurrent.com/trials/study-of-intraductal-carboplatin-in-women-with-ductal-carcinoma-in-situ-dcis-41106https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-adjuvant-treatment-with-exemestane-following-previous-treatment-with-tamoxifen-in-post-41107https://curecurrent.com/trials/tamoxifen-pharmacogenetics-and-clinical-effects-41108https://curecurrent.com/trials/aromatase-inhibitor-clinical-trial-41109https://curecurrent.com/trials/soy-selenium-and-breast-cancer-risk-41110https://curecurrent.com/trials/study-of-amrubicin-with-or-without-herceptin-in-patients-with-metastatic-breast-cancer-41111https://curecurrent.com/trials/a-study-of-women-with-an-early-diagnosis-of-breast-cancer-taking-celecoxib-between-the-biopsy-and-lumpectomy-mastectomy-41112https://curecurrent.com/trials/an-examination-of-predictors-of-indicators-of-response-to-celecoxib-in-women-who-have-a-diagnosis-of-early-breast-cancer-41113https://curecurrent.com/trials/an-examination-of-predictors-of-indicators-of-response-to-letrozole-2-5-mg-41114https://curecurrent.com/trials/use-of-a-radiolucent-pad-to-reduce-mammography-among-african-americans-41115https://curecurrent.com/trials/a-clinical-trial-to-reduce-skin-burn-induced-by-breast-radiotherapy-using-intensity-modulated-radiation-therapy-imrt-41116https://curecurrent.com/trials/peer-counseling-for-weight-loss-41117https://curecurrent.com/trials/chronic-pain-after-operation-for-breast-cancer-41118https://curecurrent.com/trials/breast-cancer-trial-of-rpr109881-versus-capecitabine-in-male-or-female-patients-with-advanced-breast-cancer-41119https://curecurrent.com/trials/same-day-dosing-of-pegfilgrastim-in-breast-cancer-patients-undergoing-chemotherapy-tac-41120https://curecurrent.com/trials/electronic-study-for-anastrozole-pharmacovigilance-evaluation-41121https://curecurrent.com/trials/a-randomised-multi-center-study-of-docetaxol-plus-capecitabine-or-cisplatin-in-anthracycline-pretreated-patients-with-ad-41122https://curecurrent.com/trials/paclitaxel-with-or-without-carboplatin-in-treating-women-with-metastatic-breast-cancer-41123https://curecurrent.com/trials/combination-chemotherapy-in-treating-older-women-with-metastatic-breast-cancer-41124https://curecurrent.com/trials/gemcitabine-and-oxaliplatin-in-treating-patients-with-metastatic-cancer-41125https://curecurrent.com/trials/docetaxel-or-paclitaxel-in-treating-women-with-unresectable-locally-advanced-or-metastatic-breast-cancer-41126https://curecurrent.com/trials/a-feasibility-study-with-iressa-in-resistant-cytokeratin-positive-tumor-cells-circulating-in-the-blood-of-women-with-bre-41127https://curecurrent.com/trials/topoisomerase-ii-alpha-gene-amplification-and-protein-overexpression-predicting-efficacy-of-epirubicin-41128https://curecurrent.com/trials/a-phase-i-study-of-eco-4601-in-patients-with-advanced-cancer-41129https://curecurrent.com/trials/preliminary-study-of-mycograb-and-docetaxel-in-advanced-breast-cancer-41130https://curecurrent.com/trials/computer-based-training-in-patients-with-post-chemotherapy-cognitive-impairment-41131https://curecurrent.com/trials/chemotherapy-on-methylation-patterns-in-breast-tumor-tissue-correlating-with-clinical-response-and-outcomes-41132https://curecurrent.com/trials/rct-of-a-group-intervention-for-women-with-a-family-history-of-breast-cancer-41133https://curecurrent.com/trials/gene-expression-profiles-in-predicting-chemotherapy-response-in-breast-cancer-41134https://curecurrent.com/trials/fulvestrant-faslodex-as-a-treatment-in-postmenopausal-women-with-estrogen-receptor-positive-breast-cancer-41135https://curecurrent.com/trials/the-monet-study-mr-mammography-of-nonpalpable-breast-tumors-41136https://curecurrent.com/trials/enzastaurin-for-breast-cancer-patients-who-previously-received-an-anthracycline-and-a-taxane-chemotherapy-41137https://curecurrent.com/trials/the-magnetic-resonance-imaging-evaluation-of-doxorubicin-cardiotoxicity-41138https://curecurrent.com/trials/cytokine-regulation-of-natural-killer-receptors-in-inhibiting-activated-t-cell-function-41139https://curecurrent.com/trials/a-trial-of-doxil-and-multiday-vinorelbine-in-patients-with-metastatic-breast-cancer-41140https://curecurrent.com/trials/correlation-between-fluorodeoxyglucose-fdg-and-flt-uptake-and-gene-expression-oncotype-assay-in-patients-with-breast-can-41141https://curecurrent.com/trials/11c-acetate-pet-ct-non-fdg-avid-tumors-41142https://curecurrent.com/trials/intraoperative-use-of-the-bp-device-for-detecting-positive-margins-during-lumpectomy-procedure-41143https://curecurrent.com/trials/weekly-taxol-plus-xeloda-vs-taxotere-q3wk-plus-xeloda-in-the-treatment-of-metastatic-bc-41144https://curecurrent.com/trials/treatment-for-elderly-patients-with-high-risk-breast-cancer-41145https://curecurrent.com/trials/vinorelbine-plus-trastuzumab-vs-docetaxel-plus-trastuzumab-as-1-line-treatment-for-her2-positive-metastatic-breast-cance-41146https://curecurrent.com/trials/pycnogenol-for-the-treatment-of-lymphedema-of-the-arm-in-breast-cancer-survivors-41147https://curecurrent.com/trials/5-fluorouracil-combined-with-cofactor-5-10-methylenetetrahydrofolate-in-treating-advanced-breast-cancer-patients-41148https://curecurrent.com/trials/comparison-of-sevoflurane-and-isoflurane-anesthesia-for-benign-breast-tumor-excision-41149https://curecurrent.com/trials/an-all-oral-combination-of-capecitabine-and-cyclophosphamide-in-patients-with-metastatic-breast-cancer-mbc-41150https://curecurrent.com/trials/examining-the-long-term-risks-of-oophorectomy-41151https://curecurrent.com/trials/docetaxel-doxorubicin-as-neoadjuvant-chemotherapy-in-patients-with-breast-cancer-41152https://curecurrent.com/trials/earlier-breast-cancer-detection-using-automated-whole-breast-ultrasound-with-mammography-including-cost-comparisons-41153https://curecurrent.com/trials/study-to-determine-the-efficacy-and-safety-of-docetaxel-and-doxorubicin-with-ingn-201-in-locally-advanced-breast-cancer-41154https://curecurrent.com/trials/a-study-of-mln8054-in-patients-with-advanced-solid-tumors-41155https://curecurrent.com/trials/acupuncture-to-treat-cancer-related-fatigue-in-breast-cancer-patients-41156https://curecurrent.com/trials/companion-pharmacogenetic-study-to-umcc-9900-9901-41157https://curecurrent.com/trials/nipple-areola-complex-conservation-41158https://curecurrent.com/trials/ax-003-arimidex-anastrozole-in-the-adjuvant-therapy-of-early-breast-cancer-41159https://curecurrent.com/trials/infrared-imaging-breast-scan-ir-for-early-breast-cancer-detection-41160https://curecurrent.com/trials/trastuzumab-optimization-trial-in-breast-cancer-41161https://curecurrent.com/trials/a-pilot-trial-of-ac-adriamycin-cyclophosphamide-chemotherapy-with-g-csf-granulocyte-colony-stimulating-factor-followed-b-41162https://curecurrent.com/trials/study-of-etoposide-in-breast-cancer-patients-41163https://curecurrent.com/trials/effect-of-preoperative-chemotherapy-on-axillary-lymph-node-metastases-in-stage-ii-breast-cancer-a-prospective-randomized-41164https://curecurrent.com/trials/antimetabolite-induction-high-dose-alkylating-agent-consolidation-and-retroviral-transduction-of-the-mdr1-gene-into-peri-41165https://curecurrent.com/trials/outcomes-of-education-and-counseling-for-brca1-testing-41166https://curecurrent.com/trials/total-body-irradiation-for-bone-marrow-transplants-collaborative-efforts-41167https://curecurrent.com/trials/a-phase-i-study-of-infusional-chemotherapy-with-the-p-glycoprotein-antagonist-psc-833-41168https://curecurrent.com/trials/phase-i-trial-of-flac-5-fluorouracil-leucovorin-adriamycin-cytoxan-plus-gm-csf-granulocyte-macrophage-colony-stimulating-41169https://curecurrent.com/trials/combination-chemotherapy-flac-combined-with-granulocyte-macrophage-colony-stimulating-factor-in-locally-advanced-and-met-41170https://curecurrent.com/trials/feasibility-study-of-interleukin-1-alpha-with-ifosfamide-cbdca-and-etoposide-with-autologous-bone-marrow-transplant-in-m-41171https://curecurrent.com/trials/a-phase-i-study-of-infusional-paclitaxel-with-the-p-glycoprotein-antagonist-psc-833-41172https://curecurrent.com/trials/a-prospective-randomized-phase-iii-trial-of-flac-5-fluorouracil-leucovorin-adriamycin-cytoxan-chemotherapy-with-gm-csf-g-41173https://curecurrent.com/trials/a-pilot-trial-of-sequential-chemotherapy-with-antimetabolite-induction-high-dose-alkylating-agent-consolidation-with-per-41174https://curecurrent.com/trials/autologous-t-cell-transplantation-and-the-immunotherapy-of-residual-disease-in-breast-cancer-pilot-study-of-vaccine-driv-41175https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-suppression-of-human-antimouse-antibody-and-human-antitoxin-response-to-immunotoxin-lmb-1-b-41176https://curecurrent.com/trials/establishment-of-normal-breast-epithelial-cell-lines-from-patients-at-high-risk-for-breast-cancer-41177https://curecurrent.com/trials/a-phase-i-trial-of-continuous-infusion-ucn-01-in-patients-with-refractory-neoplasms-41178https://curecurrent.com/trials/a-pilot-trial-of-tamoxifen-and-4-hpr-4-n-hydroxyphenyl-retinamide-in-persons-at-high-risk-for-developing-breast-cancer-41179https://curecurrent.com/trials/analysis-of-brain-metastasis-in-patients-with-breast-cancer-with-and-without-over-expression-of-her-2-41180https://curecurrent.com/trials/vinorelbine-and-xr9576-to-treat-cancer-41181https://curecurrent.com/trials/effects-of-raloxifene-on-the-uterus-and-ovaries-of-premenopausal-patients-41182https://curecurrent.com/trials/effects-of-raloxifene-on-hormone-levels-41183https://curecurrent.com/trials/positron-emission-tomography-in-patients-with-breast-cancer-41184https://curecurrent.com/trials/use-of-dynamic-contrast-enhanced-magnetic-resonance-imaging-to-assess-tumor-associated-vasculature-in-patients-with-meta-41185https://curecurrent.com/trials/a-phase-i-trial-of-tamoxifen-and-9-cis-retinoic-acid-in-breast-cancer-patients-41186https://curecurrent.com/trials/a-multimodality-treatment-approach-to-patients-with-inflammatory-cancer-of-the-breast-and-locally-advanced-non-inflammat-41187https://curecurrent.com/trials/metronomic-oral-vinorelbine-in-patients-with-metastatic-tumors-41188https://curecurrent.com/trials/how-breast-conservative-surgery-bcs-affects-women-s-daily-activities-on-post-operation-2-days-41189https://curecurrent.com/trials/guaran-for-radiation-related-fatigue-in-breast-cancer-patients-41190https://curecurrent.com/trials/compare-the-value-of-prophylactic-versus-therapeutic-breast-radiotherapy-in-casodex-41191https://curecurrent.com/trials/safety-and-immunological-response-rate-study-of-theratope-vaccine-in-metastatic-breast-cancer-patients-41192https://curecurrent.com/trials/randomized-phase-iii-trial-comparing-sequential-administration-of-fe75c-followed-by-docetaxel-versus-paclitaxel-as-adjuv-41193https://curecurrent.com/trials/dendritic-cell-based-therapy-of-metastatic-breast-cancer-41194https://curecurrent.com/trials/educational-interventions-for-patients-with-dcis-41195https://curecurrent.com/trials/cognitive-behavioral-therapy-cbt-and-physical-exercise-for-climacteric-symptoms-in-breast-cancer-patients-experiencing-t-41196https://curecurrent.com/trials/treatment-for-patients-suffering-from-anemia-due-to-chemotherapy-41197https://curecurrent.com/trials/evaluation-of-maxy-g34-in-breast-cancer-patients-treated-with-tac-docetaxel-adriamycin-cyclophosphamide-chemotherapy-41198https://curecurrent.com/trials/study-of-xyotax-ct-2103-in-patients-with-metastatic-breast-cancer-41199https://curecurrent.com/trials/effects-of-tibilone-on-bone-density-menopause-symptoms-and-breast-density-in-women-after-prophylactic-oophorectomy-41200https://curecurrent.com/trials/high-dose-rate-intracavitary-brachytherapy-as-the-sole-method-of-radiation-therapy-for-breast-carcinoma-41201https://curecurrent.com/trials/fulvestrant-in-premenopausal-women-with-hormone-receptor-positive-breast-cancer-41202https://curecurrent.com/trials/combination-weekly-taxotere-with-iressa-placebo-in-metastatic-breast-cancer-41203https://curecurrent.com/trials/therapy-with-docetaxel-and-zd1839-for-patients-who-have-advanced-breast-cancer-41204https://curecurrent.com/trials/taxotere-plus-weekly-navelbine-and-g-csf-a-study-in-stage-iv-breast-cancer-41205https://curecurrent.com/trials/a-study-of-pemetrexed-plus-doxorubicin-given-to-patients-with-advanced-breast-cancer-41206https://curecurrent.com/trials/a-study-of-abt-751-in-patients-with-recurrent-breast-cancer-after-taxane-taxol-or-taxotere-therapy-41207https://curecurrent.com/trials/diagnostics-and-therapy-of-disease-related-quality-of-life-of-patients-with-breast-cancer-41208https://curecurrent.com/trials/a-pilot-study-evaluation-of-the-efficacy-of-sonovue-to-detect-and-characterise-breast-lesions-41209https://curecurrent.com/trials/gemcitabine-plus-cisplatin-single-dose-versus-split-dose-in-the-treatment-of-patients-with-locally-advanced-or-metastati-41210https://curecurrent.com/trials/reduced-dexamethasone-pre-medication-dose-in-elderly-patients-receiving-weekly-docetaxel-41211https://curecurrent.com/trials/breast-study-to-determine-the-ability-of-non-invasive-optical-transillumination-spectroscopy-to-predict-breast-density-41212https://curecurrent.com/trials/psychosocial-study-on-breast-cancer-risk-assessment-41213https://curecurrent.com/trials/continuous-temozolomide-in-patients-with-advanced-or-metastatic-soft-tissue-sarcoma-or-metastatic-breast-cancer-41214https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-safety-and-activities-of-ew02-in-reducing-neutropenia-caused-by-chemotherapy-41215https://curecurrent.com/trials/dose-dense-chemotherapy-plus-bevacizumab-in-high-risk-lymph-node-positive-breast-cancer-a-pilot-study-41216https://curecurrent.com/trials/pet-imaging-to-determine-the-role-of-pet-in-the-assessment-of-regional-disease-in-breast-cancer-pet-predict-trial-41217https://curecurrent.com/trials/german-preoperative-adriamycin-docetaxel-study-41218https://curecurrent.com/trials/arimidex-observational-reason-for-and-effect-of-change-from-tamoxifen-41219https://curecurrent.com/trials/role-of-cytochrome-p450-2d6-cyp2d6-4-polymorphism-in-malignant-breast-diseases-41220https://curecurrent.com/trials/dyadic-coping-in-breast-and-prostate-cancer-patients-and-their-spouses-41221https://curecurrent.com/trials/effect-of-counseling-on-psychological-stress-amongst-women-felt-to-be-at-high-risk-for-breast-cancer-development-41222https://curecurrent.com/trials/a-trial-for-her2-positive-breast-cancer-patients-with-metastatic-disease-41223https://curecurrent.com/trials/adjunctive-efficacy-study-of-the-softscan-optical-breast-imaging-system-41224https://curecurrent.com/trials/treatment-and-survival-continuation-study-of-atamestane-plus-toremifene-vs-letrozole-in-advanced-breast-cancer-41225https://curecurrent.com/trials/does-a-single-steroid-injection-reduce-the-formation-of-postmastectomy-seroma-41226https://curecurrent.com/trials/study-of-suitable-schedule-of-docetaxel-anthracycline-and-cyclophosphamide-in-adjuvant-therapy-of-beast-cancer-41227https://curecurrent.com/trials/a-trial-of-gemcitabine-combined-with-vinorelbine-as-first-line-chemotherapy-for-metastatic-breast-cancer-41228https://curecurrent.com/trials/the-cat-study-atamestane-plus-toremifene-versus-letrozole-in-advanced-breast-cancer-41229https://curecurrent.com/trials/an-intervention-to-decrease-fatigue-among-breast-cancer-survivors-41230https://curecurrent.com/trials/docetaxel-cisplatin-and-capecitabine-as-neoadjuvant-chemotherapy-for-locally-advanced-breast-cancer-41231https://curecurrent.com/trials/study-of-adriamycin-plus-cyclophosphamide-followed-by-abraxane-as-adjuvant-therapy-for-patients-with-breast-cancer-41232https://curecurrent.com/trials/potential-vertebroplasty-use-in-the-treatment-of-vertebral-metastasis-from-breast-and-prostate-cancer-41233https://curecurrent.com/trials/near-infrared-ultrasound-dual-modal-imaging-for-breast-cancer-diagnosis-41234https://curecurrent.com/trials/paravertebral-block-for-breast-surgery-41235https://curecurrent.com/trials/a-decision-aid-for-women-with-early-stage-breast-cancer-41236https://curecurrent.com/trials/the-use-of-silver-leaf-dressing-in-the-prevention-of-radiotherapy-induced-skin-reactions-41237https://curecurrent.com/trials/a-prospective-single-arm-study-to-evaluate-the-efficacy-and-safety-of-zoladex-3-6mg-combined-with-cef-chemotherapy-as-ne-41238https://curecurrent.com/trials/pemetrexed-as-first-line-chemotherapy-for-advanced-breast-cancer-41239https://curecurrent.com/trials/tamoxifen-mri-study-41240https://curecurrent.com/trials/study-for-treatment-of-moderate-or-severe-periodic-cyclic-breast-pain-41241https://curecurrent.com/trials/phase-iii-study-of-gemcitabine-plus-a-cytotoxic-agent-versus-two-cytotoxic-agents-41242https://curecurrent.com/trials/a-study-of-ly353381-arzoxifene-for-patients-who-benefitted-from-this-drug-in-other-oncology-trials-and-wished-to-continu-41243https://curecurrent.com/trials/docetaxel-followed-by-cef-cyclophosphamide-epirubicin-and-5-fluorouracil-compared-to-docetaxel-and-capecitabine-followed-41244https://curecurrent.com/trials/radiation-induced-atherosclerosis-in-breast-cancer-patients-41245https://curecurrent.com/trials/study-of-motexafin-gadolinium-and-docetaxel-for-advanced-solid-tumors-41246https://curecurrent.com/trials/a-multicenter-phase-2-study-of-ci-1040-in-patients-with-advanced-nonsmall-cell-lung-breast-colon-and-pancreatic-cancer-41247https://curecurrent.com/trials/a-phase-ii-study-of-ci-1033-in-treating-patients-with-metastatic-stage-iv-breast-cancer-41248https://curecurrent.com/trials/phase-ii-study-of-capecitabine-and-weekly-docetaxel-followed-by-capecitabine-maintenance-for-patients-with-metastatic-br-41249https://curecurrent.com/trials/triad-burden-of-illness-mucositis-study-41250https://curecurrent.com/trials/complementary-therapies-for-the-reduction-of-side-effects-during-chemotherapy-for-breast-cancer-41251https://curecurrent.com/trials/wellbutrin-xl-major-depressive-disorder-and-breast-cancer-41252https://curecurrent.com/trials/docetaxel-carboplatin-and-capecitabine-as-treatment-for-patients-with-locally-advanced-or-inflammatory-breast-cancer-bef-41253https://curecurrent.com/trials/gemcitabine-carboplatin-in-breast-cancer-41254https://curecurrent.com/trials/effect-of-ketalar-to-prevent-postoperative-chronic-pain-after-mastectomy-41255https://curecurrent.com/trials/the-role-of-calcipotriol-as-radioprotector-of-skin-41256https://curecurrent.com/trials/breast-cancer-associated-antibodies-41257https://curecurrent.com/trials/dppe-in-combination-with-epirubicin-and-cyclophosphamide-in-the-treatment-of-breast-cancer-41258https://curecurrent.com/trials/ultrasound-and-chemotherapy-of-breast-cancer-relationship-between-early-vascular-changes-of-the-tumor-and-late-tumoral-r-41259https://curecurrent.com/trials/neoadjuvant-hormonal-treatment-of-postmenopausal-women-who-have-operable-breast-cancer-41260https://curecurrent.com/trials/docetaxel-followed-by-capecitabine-versus-concomitant-docetaxel-capecitabine-for-early-stage-breast-cancer-41261https://curecurrent.com/trials/essiac-esiak-versus-placebo-to-improve-quality-of-life-in-transition-in-women-with-breast-or-ovarian-cancer-41262https://curecurrent.com/trials/sakk-a-trial-to-evaluate-antitumor-efficacy-of-faslodex-after-aromatase-inhibitor-failure-in-advanced-breast-cancer-41263https://curecurrent.com/trials/raloxifene-use-for-the-heart-41264https://curecurrent.com/trials/a-trial-of-gemcitabine-plus-paclitaxel-and-gemcitabine-plus-docetaxel-in-metastatic-breast-cancer-41265https://curecurrent.com/trials/pemetrexed-and-carboplatin-in-locally-advanced-or-metastatic-breast-cancer-41266https://curecurrent.com/trials/a-study-of-biweekly-pemetrexed-and-gemcitabine-in-patients-with-metastatic-breast-cancer-41267https://curecurrent.com/trials/letrozole-in-postmenopausal-women-at-increased-risk-for-breast-cancer-41268https://curecurrent.com/trials/use-of-hair-to-diagnose-breast-cancer-41269https://curecurrent.com/trials/study-of-gpx-100-in-the-treatment-of-metastatic-breast-cancer-41270https://curecurrent.com/trials/use-of-hair-to-diagnose-the-presence-of-breast-cancer-41271https://curecurrent.com/trials/proteomic-analysis-of-hla-complex-in-solid-cancers-breast-ovary-colon-rectum-stomach-and-pancreas-41272https://curecurrent.com/trials/study-evaluating-mst-997-in-advanced-malignant-solid-tumors-41273https://curecurrent.com/trials/expanding-rural-access-distance-delivery-of-support-41274https://curecurrent.com/trials/using-test-of-scm-for-detection-breast-cancer-41275https://curecurrent.com/trials/safety-and-efficacy-study-of-intravenous-loading-dose-of-ibandronate-in-breast-cancer-patients-41276https://curecurrent.com/trials/study-assessing-efficacy-of-zarnestra-combined-with-tamoxifen-in-patients-with-advanced-or-metastatic-breast-cancer-41277https://curecurrent.com/trials/hydralazine-and-valproate-added-to-chemotherapy-for-breast-cancer-41278https://curecurrent.com/trials/chemotherapy-for-patients-with-advanced-solid-tumors-or-non-hodgkin-s-lymphoma-41279https://curecurrent.com/trials/efficacy-and-safety-of-fibrin-sealant-vapor-heated-solvent-detergent-treated-fs-vh-s-d-for-reduction-of-lymphatic-leakag-41280https://curecurrent.com/trials/use-of-hair-to-diagnose-breast-cancer-41281https://curecurrent.com/trials/physical-activity-and-breast-cancer-risk-in-postmenopausal-women-the-shape-study-41282https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-e7070-in-metastatic-breast-cancer-patients-41283https://curecurrent.com/trials/multivitamins-do-not-improve-radiation-therapy-related-fatigue-41284https://curecurrent.com/trials/australian-screening-mammography-decision-aid-trial-asmdat-41285https://curecurrent.com/trials/neoadjuvant-endocrinotherapy-of-breast-cancer-mamma-carcinoma-with-exemestane-41286https://curecurrent.com/trials/massage-therapy-for-cancer-related-fatigue-41287https://curecurrent.com/trials/acupuncture-for-shortness-of-breath-in-cancer-patients-41288https://curecurrent.com/trials/macrobiotic-diet-and-flax-seed-effects-on-estrogens-phytoestrogens-fibrinolytic-factors-41289https://curecurrent.com/trials/phase-3-study-of-ly353381-vs-tamoxifen-in-women-with-locally-advanced-or-metastatic-breast-cancer-41290https://curecurrent.com/trials/study-of-alimta-and-epirubicin-administered-in-patients-with-locally-advanced-or-metastatic-breast-cancer-41291https://curecurrent.com/trials/a-phase-ii-study-of-a-combination-of-mta-ly231514-and-gemcitabine-in-patients-with-metastatic-breast-cancer-41292https://curecurrent.com/trials/study-of-abi-007-and-taxol-in-patients-with-metastatic-breast-cancer-41293https://curecurrent.com/trials/a-menopause-interactive-decision-aid-system-41294https://curecurrent.com/trials/partial-breast-radiation-to-the-lumpectomy-cavity-with-imrt-in-elderly-women-41295https://curecurrent.com/trials/tolerance-and-pharmacokinetics-with-capecitabine-5-out-of-7-days-regimen-41296https://curecurrent.com/trials/safety-study-of-bevacizumab-to-treat-women-with-a-history-of-breast-cancer-and-suffering-from-upper-extremity-lymphedema-41297https://curecurrent.com/trials/perioperative-chemotherapy-after-primary-chemotherapy-for-locally-advanced-breast-cancer-41298https://curecurrent.com/trials/maintenance-chemotherapy-in-metastatic-breast-cancer-41299https://curecurrent.com/trials/boost-use-in-breast-conservation-radiotherapy-41300https://curecurrent.com/trials/uft-lv-maintenance-vs-observation-in-metastatic-breast-cancer-responsive-to-chemotherapy-41301https://curecurrent.com/trials/study-of-ns-9-in-patients-with-liver-metastases-41302https://curecurrent.com/trials/stars-breast-trial-study-of-anastrozole-and-radiotherapy-sequencing-pilot-41303https://curecurrent.com/trials/myocet-docetaxel-trastuzumab-as-1st-line-treatment-of-patients-with-her-2-neu-positive-metastatic-breast-cancer-41304https://curecurrent.com/trials/6-fec-100-vs-4-fec-100-followed-by-4-taxol-in-n-breast-cancer-41305https://curecurrent.com/trials/randomized-phase-ii-trial-of-dose-dense-docetaxel-in-n-breast-cancer-41306https://curecurrent.com/trials/the-diagnostic-efficacy-of-computer-aided-detection-cad-in-full-field-digital-mammography-ffdm-a-prospective-study-41307https://curecurrent.com/trials/the-study-of-infrared-imaging-on-breast-cancer-41308https://curecurrent.com/trials/imaging-characteristics-of-breast-cancer-in-women-under-40-years-of-age-41309https://curecurrent.com/trials/proton-magnetic-resonance-spectroscopy-of-normal-breast-tissues-in-women-volunteers-41310https://curecurrent.com/trials/diet-and-breast-cancer-prevention-trial-41311https://curecurrent.com/trials/implementation-of-quality-of-life-diagnostics-and-therapy-41312https://curecurrent.com/trials/an-investigational-drug-cal-versus-zoledronic-acid-zometa-in-patients-with-breast-cancer-41313https://curecurrent.com/trials/magnetic-targeted-doxorubicin-in-treating-patients-with-cancer-metastatic-to-the-liver-41314https://curecurrent.com/trials/photodynamic-therapy-system-for-patients-with-refractory-unresponsive-solid-tumors-41315https://curecurrent.com/trials/phase-i-ii-trial-of-doxil-and-hyperthermia-for-breast-cancer-patients-with-chest-wall-recurrence-or-stage-iv-disease-wit-41316https://curecurrent.com/trials/phase-i-study-of-pn401-fluorouracil-leucovorin-and-cpt-11-in-patients-with-solid-tumors-41317https://curecurrent.com/trials/study-of-111in-dac-as-a-medical-imaging-agent-for-the-detection-of-breast-cancer-41318https://curecurrent.com/trials/niraparib-and-dostarlimab-for-the-treatment-of-small-cell-lung-cancer-and-other-high-grade-neuroendocrine-carcinomas-41319https://curecurrent.com/trials/dna-analysis-of-blood-and-tissue-from-patients-with-lung-cancer-41320https://curecurrent.com/trials/empathic-communication-skills-ecs-training-41321https://curecurrent.com/trials/chemotherapy-combined-with-immunotherapy-versus-immunotherapy-alone-for-older-adults-with-stage-iiib-iv-lung-cancer-the-41322https://curecurrent.com/trials/novel-input-screening-tool-to-improve-illness-understanding-in-patients-with-metastatic-or-incurable-lung-cancer-41323https://curecurrent.com/trials/evaluation-of-a-cancer-lysate-vaccine-and-montanide-registered-trademark-isa-51-vg-with-or-without-the-il-15-super-agoni-41324https://curecurrent.com/trials/clinical-genetics-branch-eligibility-screening-survey-41325https://curecurrent.com/trials/a-patient-and-provider-intervention-to-address-health-disparities-in-lung-cancer-screening-41326https://curecurrent.com/trials/microwave-ablation-or-wedge-resection-for-the-treatment-of-lung-sarcoma-and-colorectal-lesions-allume-study-41327https://curecurrent.com/trials/a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-non-small-cell-lung-cancer-41328https://curecurrent.com/trials/a-clinical-study-of-calderasib-mk-1084-and-other-treatments-for-participants-with-non-small-cell-lung-cancer-mk-1084-007-41329https://curecurrent.com/trials/robotic-bronchoscopy-for-small-lung-nodules-without-a-bronchus-sign-41330https://curecurrent.com/trials/well-being-and-health-related-quality-of-life-in-melanoma-patients-during-covid-19-pandemic-41331https://curecurrent.com/trials/neoadjuvant-inhaled-azacytidine-with-platinum-based-chemotherapy-and-durvalumab-medi4736-a-combined-epigenetic-immunothe-41332https://curecurrent.com/trials/walking-after-surgery-to-improve-recovery-and-outcomes-after-surgery-airtech-study-41333https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-subcutaneous-sc-versus-pembrolizumab-intravenous-iv-administered-with-platinum-doublet-ch-41334https://curecurrent.com/trials/boston-lung-cancer-study-molecular-and-genetic-analysis-of-lung-cancer-41335https://curecurrent.com/trials/nci-covid-19-in-cancer-patients-nccaps-study-41336https://curecurrent.com/trials/an-open-multicenter-phase-ii-clinical-trial-of-shr-a2009-combined-with-other-anti-tumor-therapies-for-perioperative-trea-41337https://curecurrent.com/trials/impact-of-lung-cancer-screening-with-chest-scans-combined-with-coaching-on-smoking-cessation-in-heavy-smokers-41338https://curecurrent.com/trials/a-study-of-calderasib-mk-1084-plus-pembrolizumab-mk-3475-in-participants-with-kras-g12c-mutant-non-small-cell-lung-cance-41339https://curecurrent.com/trials/a-study-of-first-line-olomorasib-ly3537982-and-pembrolizumab-with-or-without-chemotherapy-in-patients-with-advanced-kras-41340https://curecurrent.com/trials/phase-1-2-multicenter-open-label-dose-escalation-study-of-idp-121-in-patients-with-platinum-resistant-small-cell-lung-ca-41341https://curecurrent.com/trials/autologous-b7-h3-chimeric-antigen-receptor-t-cells-in-previously-treated-extensive-stage-small-cell-lung-cancer-with-rec-41342https://curecurrent.com/trials/immunotherapy-after-surgery-for-people-who-have-no-remaining-cancer-cells-after-standard-treatment-for-early-stage-non-s-41343https://curecurrent.com/trials/osimertinib-with-or-without-bevacizumab-as-initial-treatment-for-patients-with-egfr-mutant-lung-cancer-41344https://curecurrent.com/trials/substudy-01i-a-study-of-investigational-agents-in-participants-with-previously-treated-stage-iv-squamous-non-small-cell-41345https://curecurrent.com/trials/livewell-an-adapted-dialectical-behavioral-therapy-skills-training-protocol-for-patients-living-with-metastatic-lung-can-41346https://curecurrent.com/trials/safety-and-efficacy-study-in-adults-with-advanced-solid-tumors-receiving-regn13089-m404-m2980-an-antibody-drug-conjugate-41347https://curecurrent.com/trials/testing-the-addition-of-a-type-of-drug-called-immunotherapy-to-the-usual-chemotherapy-treatment-for-non-small-cell-lung-41348https://curecurrent.com/trials/feasibility-of-cell-free-dna-liquid-biopsy-in-screening-high-risk-patients-for-lung-cancer-41349https://curecurrent.com/trials/beamion-lung-3-adjuvant-zongertinib-vs-standard-treatment-in-people-with-completely-resected-stage-ii-iiib-nsclc-harbori-41350https://curecurrent.com/trials/mov19-bbz-car-t-cells-in-fra-cancers-41351https://curecurrent.com/trials/m0324-as-monotherapy-and-in-combination-with-pembrolizumab-or-chemotherapy-in-participants-with-selected-advanced-solid-41352https://curecurrent.com/trials/neoadjuvant-chemotherapy-combined-with-bispecific-antibody-versus-combined-with-monoclonal-antibody-in-locally-advanced-41353https://curecurrent.com/trials/radiotherapy-plus-anlotinib-in-la-nsclc-intolerable-to-ccrt-41354https://curecurrent.com/trials/study-of-olomorasib-ly3537982-in-combination-with-standard-of-care-in-participants-with-resected-or-unresectable-kras-g1-41355https://curecurrent.com/trials/lazertinib-pemetrexed-carboplatin-in-patients-with-egfr-sensitizing-mutation-positive-recurrent-or-metastatic-non-small-41356https://curecurrent.com/trials/a-study-of-pembrolizumab-with-or-without-chemotherapy-in-combination-with-additional-treatments-for-advanced-non-small-c-41357https://curecurrent.com/trials/personalized-accelerated-chemoradiation-pacer-for-lung-cancer-41358https://curecurrent.com/trials/mk-3475a-calderasib-mk-1084-in-completely-resected-stage-iia-iiib-n2-kras-g12cm-nsclc-mk-1084-013-41359https://curecurrent.com/trials/neoadjuvant-chemo-immunotherapy-and-surgical-resection-in-locally-advanced-non-small-cell-lung-cancer-with-n3-lymph-node-41360https://curecurrent.com/trials/a-study-of-bms-986504-monotherapy-and-in-combination-with-other-agents-in-participants-with-advanced-and-or-metastatic-s-41361https://curecurrent.com/trials/anti-mesothelin-tnaive-scm-hyp218-tnhyp218-car-t-cells-in-participants-with-mesothelin-expressing-solid-tumors-including-41362https://curecurrent.com/trials/combination-chemotherapy-with-or-without-ganitumab-in-treating-patients-with-newly-diagnosed-metastatic-ewing-sarcoma-41363https://curecurrent.com/trials/genetically-engineered-natural-killer-nk-cells-with-or-without-atezolizumab-for-the-treatment-of-non-small-cell-lung-can-41364https://curecurrent.com/trials/study-of-safety-and-tolerability-of-bca101-monotherapy-and-in-combination-therapy-in-patients-with-egfr-driven-advanced-41365https://curecurrent.com/trials/anamorelin-hydrochloride-in-reducing-anorexia-in-patients-with-advanced-non-small-cell-lung-cancer-41366https://curecurrent.com/trials/a-phase-ib-study-to-evaluate-the-safety-and-preliminary-efficacy-of-il6-receptor-antibody-sarilumab-in-combination-with-41367https://curecurrent.com/trials/pembrolizumab-with-or-without-maintenance-sacituzumab-tirumotecan-sac-tmt-mk-2870-in-metastatic-squamous-non-small-cell-41368https://curecurrent.com/trials/a-study-of-ramucirumab-ly3009806-in-combination-with-erlotinib-in-previously-untreated-participants-with-egfr-mutation-p-41369https://curecurrent.com/trials/an-open-label-randomized-study-of-neoadjuvant-nivolumab-and-chemotherapy-with-or-without-sub-ablative-stereotactic-body-41370https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-divarasib-and-pembrolizumab-versus-pembrolizumab-and-pemetrexed-and-carbop-41371https://curecurrent.com/trials/medical-access-program-for-ifinatamab-deruxtecan-in-3l-pretreated-extensive-stage-small-cell-lung-cancer-41372https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-anamorelin-hcl-for-the-treatment-of-malignancy-associated-weight-loss-and-41373https://curecurrent.com/trials/couple-based-meditation-for-metastatic-lung-cancer-patients-and-their-partners-41374https://curecurrent.com/trials/a-study-of-zipalertinib-in-patients-with-advanced-non-small-cell-lung-cancer-with-epidermal-growth-factor-receptor-egfr-41375https://curecurrent.com/trials/testing-osimertinib-as-a-treatment-for-lung-cancers-with-an-egfr-exon-20-change-41376https://curecurrent.com/trials/prehabilitation-physical-therapy-and-relaxation-intervention-program-to-promote-resiliency-and-operative-success-among-a-41377https://curecurrent.com/trials/ensartinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-di-41378https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-gocatamig-mk-6070-and-ifinatamab-deruxtecan-i-dxd-in-participants-with-re-41379https://curecurrent.com/trials/molecular-basis-of-langerhans-and-non-langerhans-cell-histiocytic-neoplasms-and-castleman-disease-41380https://curecurrent.com/trials/impact-of-a-telerehabilitation-based-therapeutic-exercise-program-on-postoperative-recovery-in-patients-with-lung-cancer-41381https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-anamorelin-hcl-for-the-treatment-of-malignancy-associated-weight-loss-and-41382https://curecurrent.com/trials/a-study-evaluating-the-safety-activity-and-pharmacokinetics-of-divarasib-as-a-single-agent-or-in-combination-with-other-41383https://curecurrent.com/trials/testing-the-addition-of-the-drug-atezolizumab-to-the-usual-radiation-treatment-for-patients-with-early-non-small-cell-lu-41384https://curecurrent.com/trials/phase-1-study-of-pf-08046033-in-advanced-solid-tumors-41385https://curecurrent.com/trials/robot-assisted-vs-video-assisted-lobectomy-for-nsclc-ravar-41386https://curecurrent.com/trials/trial-to-evaluate-acasunlimab-and-pembrolizumab-combination-superiority-over-standard-of-care-docetaxel-in-non-small-cel-41387https://curecurrent.com/trials/rollover-study-for-participants-who-have-been-treated-with-and-are-continuing-to-benefit-from-opnurasib-as-a-single-agen-41388https://curecurrent.com/trials/radiation-combined-with-bispecific-t-cell-engager-in-dll3-expressing-tumors-41389https://curecurrent.com/trials/212pb-vmt-alpha-net-in-metastatic-or-inoperable-somatostatin-receptor-positive-gastrointestinal-neuroendocrine-tumors-ph-41390https://curecurrent.com/trials/educating-smokers-about-lung-cancer-screening-using-tobacco-quitlines-41391https://curecurrent.com/trials/registry-trial-and-needs-assessment-of-patients-with-young-onset-lung-cancer-impact-of-a-dedicated-care-program-on-patie-41392https://curecurrent.com/trials/a-phase-2-open-label-randomized-multicenter-study-of-tarlatamab-dosing-regimens-in-subjects-with-sclc-41393https://curecurrent.com/trials/dyadic-yoga-intervention-in-improving-physical-performance-and-quality-of-life-in-patients-with-stage-i-iv-non-small-cel-41394https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-rina-s-in-participants-with-non-small-cell-lung-cancer-41395https://curecurrent.com/trials/lunar-2-ttfields-with-pembrolizumab-platinum-based-chemotherapy-for-metastatic-nsclc-41396https://curecurrent.com/trials/magnetic-resonance-guided-hypofractionated-adaptive-radiation-therapy-with-concurrent-chemotherapy-and-consolidation-dur-41397https://curecurrent.com/trials/embedded-palliative-care-in-managing-symptoms-in-participants-with-recurrent-stage-iii-iv-thoracic-malignancies-and-thei-41398https://curecurrent.com/trials/online-psychosocial-intervention-in-improving-social-well-being-and-support-in-women-with-stage-i-iv-non-small-cell-lung-41399https://curecurrent.com/trials/mobile-sensor-technologies-to-assess-general-symptomology-of-people-with-cancer-41400https://curecurrent.com/trials/real-world-clinical-outcomes-of-resected-alk-positive-early-stage-nsclc-patients-treated-with-alectinib-as-adjuvant-ther-41401https://curecurrent.com/trials/labyrinthin-vaccination-in-veterans-with-lung-adenocarcinoma-41402https://curecurrent.com/trials/pembro-and-vorinostat-for-patients-with-stage-iv-non-small-cell-lung-cancer-nsclc-41403https://curecurrent.com/trials/nodify-lung-testing-for-pulmonary-nodules-41404https://curecurrent.com/trials/testing-the-impact-of-an-anti-cancer-drug-atezolizumab-after-surgery-to-prevent-early-stage-non-small-cell-lung-cancer-f-41405https://curecurrent.com/trials/panitumumab-irdye800-in-detecting-cancer-in-participants-with-lung-cancer-during-surgery-41406https://curecurrent.com/trials/study-to-evaluate-adverse-events-and-efficacy-of-intravenous-iv-telisotuzumab-adizutecan-in-combination-with-a-pd-1-immu-41407https://curecurrent.com/trials/beamion-lung-1-a-study-to-test-different-doses-of-zongertinib-in-people-with-different-types-of-advanced-cancer-solid-tu-41408https://curecurrent.com/trials/study-evaluating-effectiveness-and-safety-of-zimberelimab-and-domvanalimab-in-lung-cancer-41409https://curecurrent.com/trials/a-study-to-assess-intravenous-iv-telisotuzumab-adizutecan-compared-to-standard-of-care-in-adult-participants-previously-41410https://curecurrent.com/trials/prospective-longitudinal-biocollection-in-thoracic-oncology-including-newly-diagnosed-lung-cancer-patients-41411https://curecurrent.com/trials/si-b036-st-101-in-advanced-metastatic-solid-tumors-41412https://curecurrent.com/trials/thoracic-radiotherapy-plus-egfr-tki-for-stage-iii-egfr-mutant-lung-adenocarcinoma-41413https://curecurrent.com/trials/ml-016-in-advanced-cancer-with-lung-and-or-liver-involvement-41414https://curecurrent.com/trials/a-study-to-assess-disease-activity-and-adverse-events-of-intravenous-iv-telisotuzumab-vedotin-compared-to-iv-docetaxel-i-41415https://curecurrent.com/trials/trilaciclib-vs-placebo-in-patients-with-extensive-stage-small-cell-lung-cancer-es-sclc-receiving-topotecan-41416https://curecurrent.com/trials/clinical-trial-of-lurbinectedin-as-single-agent-or-in-combination-with-irinotecan-versus-topotecan-or-irinotecan-in-pati-41417https://curecurrent.com/trials/body-composition-and-inflammatory-metabolic-indices-in-immunotherapy-treated-metastatic-non-small-cell-lung-cancer-the-s-41418https://curecurrent.com/trials/immunotherapy-chemotherapy-radiotherapy-and-surgery-for-synchronous-oligo-metastatic-nsclc-41419https://curecurrent.com/trials/compassion-based-intervention-for-lung-cancer-caregivers-cbi-lcc-41420https://curecurrent.com/trials/aumolertinib-combined-intrathecal-chemotherapy-for-leptomeningeal-metastasis-from-egfr-mutated-nsclc-and-prognostic-valu-41421https://curecurrent.com/trials/connecting-to-lungcare-41422https://curecurrent.com/trials/a-study-to-assess-adverse-events-change-in-disease-activity-of-intravenous-telisotuzumab-adizutecan-in-combination-with-41423https://curecurrent.com/trials/safety-and-efficacy-of-obx-115-in-advanced-solid-tumors-41424https://curecurrent.com/trials/radical-io-three-cycles-of-immunotherapy-without-radical-therapy-in-medically-inoperable-stage-i-non-small-cell-lung-can-41425https://curecurrent.com/trials/a-study-of-zw251-in-participants-with-advanced-solid-tumors-41426https://curecurrent.com/trials/cardiotoxicity-in-locally-advanced-lung-cancer-patients-treated-with-chemoradiation-therapy-41427https://curecurrent.com/trials/effect-of-infrared-assisted-intravenous-catheterization-on-patient-comfort-in-lung-cancer-patients-41428https://curecurrent.com/trials/clear-lung-iii-circulating-tumor-dna-guided-consolidation-chemotherapy-and-immunotherapy-41429https://curecurrent.com/trials/a-study-to-assess-adverse-events-and-change-in-disease-activity-of-intravenous-iv-telisotuzumab-adizutecan-monotherapy-o-41430https://curecurrent.com/trials/a-study-to-assess-adverse-events-and-how-intravenously-iv-infused-telisotuzumab-vedotin-abbv-399-moves-through-the-body-41431https://curecurrent.com/trials/personalizing-veterans-lung-cancer-screening-and-diagnosis-41432https://curecurrent.com/trials/phase-i-iia-study-of-azd5335-as-monotherapy-and-combination-therapy-in-participants-with-solid-tumors-41433https://curecurrent.com/trials/study-of-cord-blood-derived-mesenchymal-stem-cells-for-treatment-of-moderate-severe-or-critical-pneumonia-41434https://curecurrent.com/trials/a-study-of-targeted-post-surgery-radiation-therapy-for-non-small-cell-lung-cancer-with-remaining-lymph-node-cancer-after-41435https://curecurrent.com/trials/tissue-procurement-and-natural-history-study-of-people-with-non-small-cell-lung-cancer-small-cell-lung-cancer-extrapulmo-41436https://curecurrent.com/trials/a-phase-ii-study-of-skb264-skb118-in-nsq-nsclc-after-egfr-tki-failure-41437https://curecurrent.com/trials/sw-682-in-advanced-solid-tumors-41438https://curecurrent.com/trials/natural-killer-cells-and-bortezomib-to-treat-cancer-41439https://curecurrent.com/trials/trial-of-therapeutic-cancer-vaccine-ose2101-in-patients-with-non-small-cell-lung-cancer-and-secondary-resistance-to-immu-41440https://curecurrent.com/trials/palliative-care-intervention-in-improving-symptom-control-and-quality-of-life-in-patients-with-stage-ii-iv-non-small-cel-41441https://curecurrent.com/trials/prostate-lung-colorectal-and-ovarian-plco-cancer-screening-trial-41442https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-efficacy-of-imzokitug-in-combination-with-pumitamig-and-platinum-doublet-c-41443https://curecurrent.com/trials/population-health-management-increase-lung-cancer-screening-in-community-health-centers-lungsmart-41444https://curecurrent.com/trials/smoking-cessation-cm-for-veterans-with-or-at-risk-for-cancer-41445https://curecurrent.com/trials/a-study-to-evaluate-the-optimal-dose-adverse-events-and-change-in-disease-activity-of-intravenous-abbv-706-in-combinatio-41446https://curecurrent.com/trials/screening-for-hematology-branch-protocols-41447https://curecurrent.com/trials/evaluation-of-cell-changes-in-blood-and-tissue-in-cancers-of-the-lung-esophagus-and-lung-lining-41448https://curecurrent.com/trials/evaluation-for-nci-surgery-branch-clinical-research-protocols-41449https://curecurrent.com/trials/tissue-procurement-and-natural-history-study-of-patients-with-malignant-mesothelioma-41450https://curecurrent.com/trials/adding-certolizumab-to-chemotherapy-nivolumab-in-people-who-have-lung-cancer-that-can-be-treated-with-surgery-41451https://curecurrent.com/trials/comparison-of-in-home-versus-in-clinic-administration-of-subcutaneous-nivolumab-through-cancer-care-connected-access-and-41452https://curecurrent.com/trials/multicenter-single-arm-prospective-phase-ii-study-of-neoadjuvant-cryo-thermal-ablation-combined-with-toripalimab-and-che-41453https://curecurrent.com/trials/effect-of-trilaciclib-in-the-prevention-of-myelosupression-in-subjects-with-limited-stage-small-cell-lung-cancer-41454https://curecurrent.com/trials/a-safety-and-efficacy-study-of-eik1001-in-combination-with-pembrolizumab-and-chemotherapy-in-participants-with-stage-4-n-41455https://curecurrent.com/trials/clinical-study-of-neoadjuvant-chemotherapy-and-immunotherapy-combined-with-probiotics-in-patients-with-resectable-nsclc-41456https://curecurrent.com/trials/study-of-three-endpoints-to-assess-the-benefit-of-rehabilitation-in-patients-with-advanced-non-small-cell-lung-cancer-co-41457https://curecurrent.com/trials/blood-testing-to-detect-cancer-recurrence-in-patients-with-early-stage-non-small-cell-lung-cancer-41458https://curecurrent.com/trials/data-collection-of-standard-care-and-evaluation-of-nhlbi-patients-and-donors-41459https://curecurrent.com/trials/study-of-capmatinib-in-indian-patients-with-met-exon-14-skipping-mutation-positive-advanced-nsclc-41460https://curecurrent.com/trials/dabrafenib-and-or-trametinib-rollover-study-41461https://curecurrent.com/trials/a-study-of-mevrometostat-for-treatment-of-relapsed-refractory-sclc-castration-resistant-prostate-cancer-and-follicular-l-41462https://curecurrent.com/trials/study-of-the-disease-process-of-lymphangioleiomyomatosis-41463https://curecurrent.com/trials/phase-1-2-study-of-intravenous-injection-of-stx-003-in-advanced-solid-tumors-as-monotherapy-or-in-combination-with-pembr-41464https://curecurrent.com/trials/a-study-of-pembrolizumab-mk-3475-with-or-without-intismeran-autogene-v940-in-participants-with-non-small-cell-lung-cance-41465https://curecurrent.com/trials/prospective-multiomic-analysis-in-small-cell-lung-cancer-41466https://curecurrent.com/trials/personalized-first-line-chemotherapy-choice-in-advanced-pancreatic-adenocarcinoma-using-transcriptomic-signatures-41467https://curecurrent.com/trials/testing-the-addition-of-an-antibody-to-standard-chemoradiation-followed-by-the-antibody-for-one-year-to-standard-chemora-41468https://curecurrent.com/trials/edoxaban-versus-apixaban-in-cancer-associated-venous-thromboembolism-41469https://curecurrent.com/trials/a-clinical-trial-of-adjuvant-intismeran-v940-with-or-without-pembrolizumab-coformulated-with-berahyaluronidase-alfa-mk-3-41470https://curecurrent.com/trials/a-clinical-trial-of-calderasib-mk-1084-and-durvalumab-in-people-with-non-small-cell-lung-cancer-mk-1084-015-kandlelit-01-41471https://curecurrent.com/trials/family-caregiver-palliative-care-intervention-in-supporting-caregivers-of-patients-with-stage-ii-iv-gastrointestinal-gyn-41472https://curecurrent.com/trials/study-of-zanzalintinib-in-combination-with-immuno-oncology-or-other-agents-in-participants-with-solid-tumors-41473https://curecurrent.com/trials/genetic-testing-in-screening-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that-has-been-or-will-be-removed-by-41474https://curecurrent.com/trials/beamion-lung-2-a-study-to-test-whether-zongertinib-bi-1810631-helps-people-with-advanced-non-small-cell-lung-cancer-with-41475https://curecurrent.com/trials/sbrt-for-ultra-central-nonsmall-cell-lung-cancer-41476https://curecurrent.com/trials/a-study-of-investigational-agents-in-participants-with-previously-treated-stage-iv-nonsquamous-non-small-cell-lung-cance-41477https://curecurrent.com/trials/a-phase-ii-clinical-study-to-evaluate-hlx43-in-subjects-with-advanced-non-small-cell-lung-cancer-nsclc-41478https://curecurrent.com/trials/pds01adc-in-combination-with-hepatic-artery-infusion-pump-haip-and-systemic-therapy-for-subjects-with-metastatic-colorec-41479https://curecurrent.com/trials/a-study-of-i-dxd-in-combination-with-atezolizumab-with-or-without-carboplatin-as-first-line-induction-or-maintenance-in-41480https://curecurrent.com/trials/symptoms-physical-function-and-recovery-in-patients-receiving-lung-cancer-treatment-before-surgery-41481https://curecurrent.com/trials/study-of-palifosfamide-tris-in-combination-with-carboplatin-and-etoposide-in-chemotherapy-na-ve-patients-with-extensive-41482https://curecurrent.com/trials/a-clinical-study-of-mk-1084-with-other-treatments-for-non-small-cell-lung-cancer-mk-3475-01f-41483https://curecurrent.com/trials/a-long-term-extension-study-of-pci-32765-ibrutinib-41484https://curecurrent.com/trials/integrating-artificial-intelligence-into-lung-cancer-screening-41485https://curecurrent.com/trials/nivolumab-after-surgery-and-chemotherapy-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-an-alchemist-41486https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-08046876-in-people-with-advanced-solid-tumors-41487https://curecurrent.com/trials/erlotinib-hydrochloride-and-cabozantinib-s-malate-alone-or-in-combination-as-second-or-third-line-therapy-in-treating-pa-41488https://curecurrent.com/trials/tln-499-in-combination-with-venetoclax-in-patients-with-relapsed-refractory-solid-tumors-41489https://curecurrent.com/trials/testing-the-timing-of-pembrolizumab-alone-or-with-chemotherapy-as-first-line-treatment-and-maintenance-in-non-small-cell-41490https://curecurrent.com/trials/ai-assisted-3d-reconstruction-for-lung-resection-planning-41491https://curecurrent.com/trials/a-clinical-study-of-gocatamig-mk-6070-and-infinatamab-deruxtecan-mk-2400-in-people-with-small-cell-lung-cancer-mk-6070-0-41492https://curecurrent.com/trials/intraoperative-longitude-latitude-depth-localization-versus-preoperative-ct-guided-percutaneous-lung-puncture-localizati-41493https://curecurrent.com/trials/cemiplimab-and-fianlimab-before-surgery-for-the-treatment-of-stage-ib-iiib-non-small-cell-lung-cancer-41494https://curecurrent.com/trials/a-study-of-intismeran-autogene-v940-placebo-pembrolizumab-and-chemotherapy-in-metastatic-squamous-non-small-cell-lung-ca-41495https://curecurrent.com/trials/radiomics-for-distinguishing-benign-and-malignant-lung-nodules-41496https://curecurrent.com/trials/durvalumab-with-chemotherapy-as-first-line-treatment-in-advanced-pleural-mesothelioma-41497https://curecurrent.com/trials/early-prophylactic-versus-late-salvage-recombinant-human-endostatin-in-managing-radiosurgery-induced-brain-injury-for-ns-41498https://curecurrent.com/trials/htl0039732-in-participants-with-advanced-solid-tumours-41499https://curecurrent.com/trials/testing-the-addition-of-radiation-therapy-to-the-usual-treatment-immunotherapy-with-or-without-chemotherapy-for-advanced-41500https://curecurrent.com/trials/a-platform-study-in-non-small-cell-lung-cancer-nsclc-41501https://curecurrent.com/trials/testing-the-addition-of-radiation-therapy-to-the-usual-immune-therapy-treatment-atezolizumab-for-extensive-stage-small-c-41502https://curecurrent.com/trials/study-to-assess-safety-and-efficacy-of-atezolizumab-mpdl3280a-compared-to-best-supportive-care-following-chemotherapy-in-41503https://curecurrent.com/trials/lung-epicheck-biomarkers-development-study-41504https://curecurrent.com/trials/vortosiran-for-vte-prevention-41505https://curecurrent.com/trials/a-pilot-study-of-blood-based-biomarkers-for-response-to-immune-checkpoint-inhibitors-41506https://curecurrent.com/trials/atezolizumab-in-combination-with-stereotactic-body-radiation-therapy-sbrt-and-surgery-for-relapsed-osteosarcoma-41507https://curecurrent.com/trials/a-study-to-test-how-bi-765063-and-bi-770371-are-taken-up-in-tumours-of-people-with-different-types-of-advanced-cancer-wh-41508https://curecurrent.com/trials/an-exploratory-clinical-study-of-bempemab-combined-with-anlotinib-as-first-line-treatment-for-elderly-patients-with-loca-41509https://curecurrent.com/trials/repotrectinib-post-marketing-surveillance-in-korean-patients-with-ros1-positive-non-small-cell-lung-cancer-nsclc-or-soli-41510https://curecurrent.com/trials/neladalkib-nvl-655-for-tki-naive-patients-with-advanced-alk-positive-nsclc-41511https://curecurrent.com/trials/a-study-to-evaluate-pumitamig-versus-durvalumab-following-concurrent-chemoradiation-therapy-in-participants-with-unresec-41512https://curecurrent.com/trials/a-first-in-human-study-of-alx2004-with-advanced-or-metastatic-selected-solid-tumors-41513https://curecurrent.com/trials/a-study-of-alisertib-and-paclitaxel-in-patients-with-small-cell-lung-cancer-sclc-41514https://curecurrent.com/trials/dareon-8-a-study-to-test-how-well-different-doses-of-bi-764532-in-addition-to-standard-of-care-are-tolerated-by-people-w-41515https://curecurrent.com/trials/plasma-proteomic-biomarkers-for-early-diagnosis-of-lung-cancer-41516https://curecurrent.com/trials/a-phase-1-first-in-human-fih-open-label-dose-escalation-and-dose-expansion-study-of-the-peptide-drug-conjugate-pdc-ts-10-41517https://curecurrent.com/trials/adaptive-ctdna-based-personalization-of-treatment-during-consolidation-therapy-in-nsclc-41518https://curecurrent.com/trials/a-study-of-poziotinib-in-previously-treated-participants-with-locally-advanced-or-metastatic-nsclc-harboring-her2-exon-2-41519https://curecurrent.com/trials/a-study-to-test-obrixtamig-in-combination-with-pumitamig-in-people-with-advanced-small-cell-lung-cancer-dareon-rosetta35-41520https://curecurrent.com/trials/risk-based-lung-cancer-detection-in-copd-patients-41521https://curecurrent.com/trials/determination-and-validation-of-a-multi-analyte-assay-for-lung-cancer-screening-41522https://curecurrent.com/trials/a-phase-1-clinical-study-of-nxp900-in-subjects-with-advanced-cancers-41523https://curecurrent.com/trials/a-phase-1-dose-escalation-study-of-225ac-fpi-2068-in-adult-patients-with-advanced-solid-tumours-41524https://curecurrent.com/trials/phase-3-study-of-sitravatinib-plus-nivolumab-vs-docetaxel-in-patients-with-advanced-non-squamous-non-small-cell-lung-can-41525https://curecurrent.com/trials/video-guided-versus-conventional-right-sided-double-lumen-tube-placement-for-thoracoscopic-surgery-41526https://curecurrent.com/trials/augmented-endobronchial-ultrasound-ebus-tbna-with-artificial-intelligence-41527https://curecurrent.com/trials/temozolomide-with-or-without-veliparib-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer-41528https://curecurrent.com/trials/improving-surgeon-performance-measures-for-robot-assisted-surgery-41529https://curecurrent.com/trials/a-study-of-atezolizumab-in-high-pd-l1-expression-chemotherapy-na-ve-patients-with-stage-iv-non-squamous-or-squamous-non-41530https://curecurrent.com/trials/diagnostic-performance-of-small-rna-blood-test-in-patients-undergoing-follow-up-imaging-after-positive-low-dose-ct-scree-41531https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-pumitamig-versus-pembrolizumab-in-participants-with-previously-untreated-advanced-no-41532https://curecurrent.com/trials/universal-immunization-to-fortify-immunotherapy-efficacy-and-response-41533https://curecurrent.com/trials/a-clinical-study-of-hs-it101-injection-in-patients-with-advanced-non-small-cell-lung-cancer-41534https://curecurrent.com/trials/dk222-study-at-hopkins-41535https://curecurrent.com/trials/small-middle-tier-cities-and-county-lung-cancer-quality-improvement-project-qip-study-41536https://curecurrent.com/trials/stereotactic-radiation-in-patients-with-small-cell-lung-cancer-and-1-10-brain-metastases-41537https://curecurrent.com/trials/dareon-lung-1-a-study-in-people-with-advanced-small-cell-lung-cancer-to-compare-obrixtamig-plus-atezolizumab-carboplatin-41538https://curecurrent.com/trials/regn7508-in-adult-participants-for-prevention-of-cancer-associated-thrombosis-41539https://curecurrent.com/trials/dendritic-cell-therapy-combined-with-surgery-in-mesothelioma-41540https://curecurrent.com/trials/docetaxel-plus-plinabulin-vs-docetaxel-plus-placebo-in-advanced-metastatic-non-squamous-nsclc-after-pd-1-pd-l1-therapy-a-41541https://curecurrent.com/trials/a-phase-i-ii-study-of-hypofractionated-proton-therapy-for-stage-ii-iii-non-small-cell-lung-cancer-41542https://curecurrent.com/trials/zanzalintinib-and-pembrolizumab-in-first-line-maintenance-for-metastatic-squamous-non-small-cell-lung-cancer-nsclc-41543https://curecurrent.com/trials/in-vivo-lung-perfusion-ivlp-for-colorectal-cancer-metastatic-to-lung-41544https://curecurrent.com/trials/testing-the-addition-of-the-pill-chemotherapy-cabozantinib-to-the-standard-immune-therapy-nivolumab-compared-to-standard-41545https://curecurrent.com/trials/quad-shot-radiotherapy-combined-with-tislelizumab-and-platinum-based-chemotherapy-before-surgery-for-stage-ii-iii-non-sm-41546https://curecurrent.com/trials/study-of-daraxonrasib-rmc-6236-in-patients-with-ras-mutated-nsclc-rasolve-301-41547https://curecurrent.com/trials/a-study-of-phn-012-in-patients-with-advanced-solid-tumors-41548https://curecurrent.com/trials/intravenous-palifosfamide-tris-in-combination-with-etoposide-and-carboplatin-in-patients-with-malignancies-41549https://curecurrent.com/trials/dbc-664-in-adult-patients-with-solid-tumors-41550https://curecurrent.com/trials/perioperative-retlirafusp-alfa-anti-pd-l1-tgf-bifunctional-fusion-protein-plus-famitinib-and-gemox-based-hepatic-arteria-41551https://curecurrent.com/trials/dareon-36-a-study-to-test-obrixtamig-in-combination-with-zl-1310-in-people-with-advanced-small-cell-lung-cancer-or-other-41552https://curecurrent.com/trials/amivantamab-with-tyrosine-kinase-inhibitors-tki-for-advanced-nsclc-with-alk-ros1-or-ret-alterations-41553https://curecurrent.com/trials/pharmacogenomics-ind-snp-clinical-trial-alectinib-and-single-nucleotide-polymorphisms-41554https://curecurrent.com/trials/the-effect-of-music-on-anxiety-and-caregiver-burden-in-family-caregivers-of-patients-with-lung-cancer-41555https://curecurrent.com/trials/this-is-a-multicenter-open-label-phase-i-ii-study-to-explore-the-safety-tolerability-pharmacokinetics-pk-and-preliminary-41556https://curecurrent.com/trials/volrustomig-priming-regimens-exploratory-phase-ii-platform-study-41557https://curecurrent.com/trials/a-first-in-human-study-of-prth-101-monotherapy-pembrolizumab-in-subjects-with-advanced-malignancies-41558https://curecurrent.com/trials/apixaban-to-prevent-venous-thromboembolism-in-ambulatory-lung-cancer-patients-undergoing-systemic-anticancer-treatment-41559https://curecurrent.com/trials/study-of-pembrolizumab-with-maintenance-olaparib-or-maintenance-pemetrexed-in-first-line-1l-metastatic-nonsquamous-non-s-41560https://curecurrent.com/trials/a-study-of-lazertinib-with-subcutaneous-amivantamab-compared-with-intravenous-amivantamab-in-participants-with-epidermal-41561https://curecurrent.com/trials/treatment-and-secondary-prevention-of-venous-thromboembolism-vte-in-adult-participants-with-solid-and-hematologic-cancer-41562https://curecurrent.com/trials/covid-19-experiences-in-the-self-cohort-41563https://curecurrent.com/trials/nis-to-examine-the-effectiveness-of-tdc-in-patients-with-metastatic-non-squamous-nsclc-and-high-risk-genetic-alterations-41564https://curecurrent.com/trials/a-clinical-study-to-assess-the-efficacy-of-adjuvant-immunotherapy-with-cemiplimab-in-patients-with-surgically-removed-no-41565https://curecurrent.com/trials/a-study-of-gsk5764227-in-participants-with-relapsed-small-cell-lung-cancer-sclc-embold-sclc-301-41566https://curecurrent.com/trials/symbiotic-lung-14-a-study-to-learn-about-the-study-medicine-called-pf08634404-in-combination-with-chemotherapy-in-adult-41567https://curecurrent.com/trials/biospecimen-procurement-for-center-for-immuno-oncology-immunotherapy-protocols-41568https://curecurrent.com/trials/a-study-of-amivantamab-in-participants-with-advanced-or-metastatic-solid-tumors-including-epidermal-growth-factor-recept-41569https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-for-oligo-progressive-non-small-cell-lung-cancer-41570https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-08046054-sgn-pdl1v-versus-docetaxel-in-adult-participants-with-previ-41571https://curecurrent.com/trials/pembrolizumab-mk-3475-plus-investigational-agents-in-resectable-non-small-cell-lung-cancer-nsclc-mk-3475-01e-keymaker-u0-41572https://curecurrent.com/trials/symbiotic-lung-04-a-study-to-learn-about-the-study-medicine-called-pf-08634404-in-combination-with-chemotherapy-in-adult-41573https://curecurrent.com/trials/sparc-screening-for-lung-cancer-with-platelets-via-an-ai-enabled-rna-based-classifier-41574https://curecurrent.com/trials/a-study-of-amivantamab-and-lazertinib-in-combination-with-platinum-based-chemotherapy-compared-with-platinum-based-chemo-41575https://curecurrent.com/trials/genetic-analysis-of-birt-hogg-dube-syndrome-and-characterization-of-predisposition-to-kidney-cancer-41576https://curecurrent.com/trials/a-study-of-amivantamab-and-lazertinib-combination-therapy-versus-osimertinib-in-locally-advanced-or-metastatic-non-small-41577https://curecurrent.com/trials/a-study-of-ide892-as-monotherapy-and-combination-in-mtap-deleted-advanced-solid-tumors-41578https://curecurrent.com/trials/local-consolidative-therapy-versus-maintenance-immunotherapy-after-first-line-chemoimmunotherapy-in-metastatic-nsclc-41579https://curecurrent.com/trials/a-prospective-multicenter-randomized-controlled-study-on-the-efficacy-and-safety-of-low-dose-carboplatin-combined-with-n-41580https://curecurrent.com/trials/enhanced-dermatological-care-to-reduce-rash-and-paronychia-in-epidermal-growth-factor-receptor-egrf-mutated-non-small-ce-41581https://curecurrent.com/trials/destiny-pantumour04-41582https://curecurrent.com/trials/evaluating-the-preliminary-efficacy-and-safety-of-js207-in-nsclc-after-progression-following-platinum-based-chemotherapy-41583https://curecurrent.com/trials/sacituzumab-tirumotecan-mk-2870-in-combination-with-pembrolizumab-versus-pembrolizumab-alone-in-metastatic-non-small-cel-41584https://curecurrent.com/trials/hypofraction-radiotherapy-for-locally-advanced-non-small-cell-lung-cancer-41585https://curecurrent.com/trials/ph1-2-trial-of-navlimetostat-with-pumitamig-in-mtap-deficient-advanced-non-small-cell-lung-cancer-41586https://curecurrent.com/trials/a-study-of-jnj-86974680-in-participants-with-advanced-non-small-cell-lung-cancer-41587https://curecurrent.com/trials/dyadic-yoga-program-for-patients-undergoing-thoracic-radiotherapy-and-their-family-caregivers-the-testing-of-a-mobile-ap-41588https://curecurrent.com/trials/osireal-osimertinib-rwe-on-egfrm-nsclc-in-spain-41589https://curecurrent.com/trials/ai-assisted-management-of-pulmonary-nodules-found-on-low-dose-ct-in-health-screening-41590https://curecurrent.com/trials/a-study-evaluating-sotorasib-platinum-doublet-combination-versus-pembrolizumab-platinum-doublet-combination-as-a-front-l-41591https://curecurrent.com/trials/a-study-of-amivantamab-in-combination-with-lazertinib-or-amivantamab-in-combination-with-platinum-based-chemotherapy-for-41592https://curecurrent.com/trials/a-web-based-program-to-help-caregivers-of-lung-patients-learn-about-available-supportive-care-resources-41593https://curecurrent.com/trials/neoadjuvant-furmonertinib-and-cisplatin-pemetrexed-as-in-egfr-mutated-stage-iia-iiib-resectable-nsclc-foresee-41594https://curecurrent.com/trials/first-in-human-study-of-azd9592-in-solid-tumors-41595https://curecurrent.com/trials/a-new-way-to-share-radiation-therapy-plans-between-doctors-correct-trial-41596https://curecurrent.com/trials/pilot-study-of-performance-status-2-vs-performance-status-0-1-non-small-cell-lung-cancer-patients-treated-with-chemo-imm-41597https://curecurrent.com/trials/a-study-of-amivantamab-and-olomorasib-combination-therapy-in-participants-with-metastatic-non-small-cell-lung-cancer-41598https://curecurrent.com/trials/cardiorespiratory-fitness-after-lobectomy-versus-sublobar-resection-41599https://curecurrent.com/trials/a-global-phase-iii-study-of-rilvegostomig-or-pembrolizumab-monotherapy-for-first-line-treatment-of-pd-l1-high-metastatic-41600https://curecurrent.com/trials/a-study-of-shr-a2009-combined-with-aumolertinib-versus-aumolertinib-for-first-line-treatment-in-egfr-mutated-advanced-or-41601https://curecurrent.com/trials/a-study-of-clinical-outcomes-in-participants-with-egfr-mutated-advanced-non-small-cell-lung-cancer-nsclc-in-a-real-world-41602https://curecurrent.com/trials/phase-1-study-of-atra-plus-a-pd-1-inhibitor-in-egfr-mutant-nsclc-after-third-generation-egfr-tki-resistance-41603https://curecurrent.com/trials/a-study-to-investigate-ubamatamab-with-and-without-marlotamig-regn7075-in-adult-participants-with-advanced-metastatic-no-41604https://curecurrent.com/trials/a-study-of-combination-therapy-with-amivantamab-and-cetrelimab-in-participants-with-metastatic-non-small-cell-lung-cance-41605https://curecurrent.com/trials/a-study-of-jnj-90301900-in-combination-with-chemoradiation-followed-by-consolidation-immunotherapy-for-non-small-cell-lu-41606https://curecurrent.com/trials/phase-1-study-to-investigate-tcrts-kras-mutation-in-unresectable-advanced-and-or-metastatic-solid-tumors-41607https://curecurrent.com/trials/a-study-of-neoadjuvant-amivantamab-with-either-lazertinib-or-chemotherapy-in-participants-with-resectable-egfr-mutated-n-41608https://curecurrent.com/trials/a-study-of-tarlatamab-in-combination-with-ab248-in-participants-with-extensive-stage-small-cell-lung-cancer-dellphi-311-41609https://curecurrent.com/trials/study-of-jdq443-in-comparison-with-docetaxel-in-participants-with-locally-advanced-or-metastatic-kras-g12c-mutant-non-sm-41610https://curecurrent.com/trials/m6620-and-irinotecan-hydrochloride-in-treating-patients-with-solid-tumors-that-are-metastatic-or-cannot-be-removed-by-su-41611https://curecurrent.com/trials/a-randomized-controlled-trial-comparing-percutaneous-ct-guided-biopsy-and-shape-sensing-robotic-assisted-bronchoscopy-41612https://curecurrent.com/trials/immune-microenvironment-and-gene-expression-profiling-in-mesothelioma-41613https://curecurrent.com/trials/study-of-amivantamab-a-human-bispecific-egfr-and-cmet-antibody-in-participants-with-advanced-non-small-cell-lung-cancer-41614https://curecurrent.com/trials/neoadjuvant-nivolumab-with-ccr2-5-inhibitor-or-anti-il-8-for-non-small-cell-lung-cancer-nsclc-or-hepatocellular-carcinom-41615https://curecurrent.com/trials/symbiotic-lung-10-a-study-to-learn-about-pf-08634404-alone-or-in-combination-in-early-stage-or-locally-advanced-nsclc-41616https://curecurrent.com/trials/symbiotic-lung-01-a-study-to-learn-about-the-study-medicine-called-pf-08634404-in-combination-with-chemotherapy-in-adult-41617https://curecurrent.com/trials/evaluation-of-xya02-in-patients-with-advanced-solid-tumors-41618https://curecurrent.com/trials/immunotherapy-without-chemotherapy-for-advanced-lung-cancer-patients-with-high-pd-l1-levels-41619https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-pembrolizumab-with-or-without-sacituzumab-tirumotecan-mk-2870-in-adult-particip-41620https://curecurrent.com/trials/symbiotic-lung-20-a-study-to-learn-about-the-study-medicine-called-pf-08634404-in-combination-with-different-anticancer-41621https://curecurrent.com/trials/a-study-of-amivantamab-and-capmatinib-combination-therapy-in-unresectable-metastatic-non-small-cell-lung-cancer-41622https://curecurrent.com/trials/this-is-a-study-to-learn-about-how-the-combination-of-the-study-medicines-sigvotatug-vedotin-plus-pembrolizumab-works-in-41623https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-ponsegromab-in-adults-with-lung-cancer-associated-significant-body-weig-41624https://curecurrent.com/trials/trabedersen-ot-101-with-pembrolizumab-for-newly-diagnosed-advanced-nsclc-and-positive-pd-l1-41625https://curecurrent.com/trials/premedication-to-reduce-amivantamab-associated-infusion-related-reactions-41626https://curecurrent.com/trials/a-phase-i-dose-escalation-and-dose-expansion-study-to-investigate-the-pharmacokinetics-and-safety-of-subcutaneous-durval-41627https://curecurrent.com/trials/an-observational-study-to-assess-the-effectiveness-and-safety-of-a-cemiplimab-in-adult-patients-with-advanced-non-small-41628https://curecurrent.com/trials/phase-2-docerampem-for-patients-with-metastatic-or-recurrent-nsclc-who-progressed-on-platinum-doublet-and-pd-1-pd-l1-blo-41629https://curecurrent.com/trials/a-study-of-tak-186-also-known-as-mvc-101-in-adults-with-advanced-or-metastatic-cancer-41630https://curecurrent.com/trials/study-of-dato-dxd-plus-pembrolizumab-vs-pembrolizumab-alone-in-the-first-line-treatment-of-subjects-with-advanced-or-met-41631https://curecurrent.com/trials/a-study-of-dxc006-with-immune-checkpoint-inhibitors-or-platinum-for-small-cell-lung-cancer-41632https://curecurrent.com/trials/the-april-trial-evaluating-upfront-stereotactic-body-radiotherapy-in-stage-iii-advanced-non-small-cell-lung-cancer-41633https://curecurrent.com/trials/an-adjuvant-study-to-evaluate-sms001-paclitaxel-in-non-small-cell-lung-cancer-41634https://curecurrent.com/trials/pan-tumor-mrd-study-41635https://curecurrent.com/trials/using-e-nose-technology-to-measure-response-to-treatment-in-people-with-malignant-pleural-mesothelioma-41636https://curecurrent.com/trials/safety-and-efficacy-of-neo212-in-patients-with-astrocytoma-idh-mutant-glioblastoma-idh-wildtype-or-brain-metastasis-41637https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-pf-07934040-when-given-alone-or-with-other-anti-cancer-therapies-in-people-wit-41638https://curecurrent.com/trials/a-phase-3-study-of-sosimerasib-in-combination-with-in10018-versus-standard-therapy-for-first-line-non-squamous-non-small-41639https://curecurrent.com/trials/mind-well-intervention-41640https://curecurrent.com/trials/placebo-controlled-study-of-concurrent-chemoradiation-therapy-with-pembrolizumab-followed-by-pembrolizumab-and-olaparib-41641https://curecurrent.com/trials/a-study-of-additional-chemotherapy-after-surgery-for-people-with-malignant-peritoneal-mesothelioma-41642https://curecurrent.com/trials/a-registry-for-people-with-lung-cancer-41643https://curecurrent.com/trials/real-world-study-of-aumolertinib-in-patients-with-advanced-egfr-t790m-positive-nsclc-41644https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-bms-986489-in-chinese-participa-41645https://curecurrent.com/trials/imaging-and-blood-based-biomarkers-for-the-evaluation-of-early-signs-of-myocardial-injury-after-thoracic-radiation-thera-41646https://curecurrent.com/trials/a-study-of-risvutatug-rezetecan-in-combination-with-ivonescimab-in-participants-with-advanced-solid-tumors-embold-pantum-41647https://curecurrent.com/trials/additional-chemotherapy-administered-directly-into-the-liver-using-a-chemo-pump-in-patients-with-bile-duct-cancer-inside-41648https://curecurrent.com/trials/trastuzumab-rezetecan-and-adebrelimab-alone-or-in-combination-after-chemoradiotherapy-for-her2-altered-unresectable-stag-41649https://curecurrent.com/trials/a-study-of-zen003694-in-people-with-squamous-cell-lung-cancer-41650https://curecurrent.com/trials/lorlatinib-continuation-study-41651https://curecurrent.com/trials/a-study-of-gilteritinib-in-adults-with-advanced-alk-positive-non-small-cell-lung-cancer-nsclc-41652https://curecurrent.com/trials/adjuvant-egfr-tki-therapy-after-surgery-for-egfr-mutant-high-risk-stage-ia2-iib-nsclc-41653https://curecurrent.com/trials/testing-repeat-radiation-therapy-for-recurrent-non-small-cell-lung-cancer-41654https://curecurrent.com/trials/high-fermented-food-intervention-among-locally-advanced-rectal-cancer-patients-the-feed-trial-41655https://curecurrent.com/trials/race-2l-real-world-assessment-of-clinical-practice-and-outcomes-in-non-squamous-nsclc-after-failure-of-platinum-based-ch-41656https://curecurrent.com/trials/immune-profile-selection-by-fraction-of-ctdna-in-patients-with-advanced-nsclc-treated-with-immunotherapy-41657https://curecurrent.com/trials/phase-iii-open-label-study-of-first-line-dato-dxd-in-combination-with-rilvegostomig-for-advanced-non-squamous-nsclc-with-41658https://curecurrent.com/trials/efficacy-and-safety-of-conventional-and-low-dose-platinum-gemcitabine-combined-with-sintilimab-with-delayed-administrati-41659https://curecurrent.com/trials/a-study-to-compare-the-efficacy-of-nivolumab-and-relatlimab-plus-chemotherapy-vs-pembrolizumab-plus-chemotherapy-for-sta-41660https://curecurrent.com/trials/a-study-to-compare-the-combination-of-navlimetostat-bms-986504-with-pembrolizumab-and-chemotherapy-versus-placebo-plus-p-41661https://curecurrent.com/trials/chio3-trial-chemotherapy-combined-with-immune-checkpoint-inhibitor-for-operable-stage-iiia-b-non-small-cell-lung-cancer-41662https://curecurrent.com/trials/neoadjuvant-and-adjuvant-treatment-in-resectable-non-small-cell-lung-cancer-41663https://curecurrent.com/trials/a-study-to-learn-more-about-how-well-sevabertinib-works-and-how-safe-it-is-compared-with-standard-treatment-in-participa-41664https://curecurrent.com/trials/a-phase-iii-randomised-study-of-adjuvant-dato-dxd-in-combination-with-rilvegostomig-or-rilvegostomig-monotherapy-versus-41665https://curecurrent.com/trials/adp-a2m4cd8-as-monotherapy-or-in-combination-with-either-nivolumab-or-pembrolizumab-in-hla-a2-subjects-with-mage-a4-posi-41666https://curecurrent.com/trials/a-study-to-evaluate-adverse-events-and-change-in-disease-activity-of-intravenous-abbv-706-versus-standard-of-care-in-adu-41667https://curecurrent.com/trials/oleclumab-medi9447-epidermal-growth-factor-receptor-mutant-egfrm-non-small-cell-lung-cancer-nsclc-novel-combination-stud-41668https://curecurrent.com/trials/a-study-of-dxc014-in-patients-with-advanced-solid-tumors-41669https://curecurrent.com/trials/a-global-phase-iii-study-of-rilvegostomig-or-pembrolizumab-plus-chemotherapy-for-first-line-treatment-of-locally-advance-41670https://curecurrent.com/trials/bright-light-therapy-in-patients-with-melanoma-or-non-small-cell-lung-cancer-nsclc-who-are-receiving-first-line-immune-c-41671https://curecurrent.com/trials/a-study-of-selpercatinib-ly3527723-in-participants-with-rearranged-during-transfection-ret-altered-cancers-in-india-41672https://curecurrent.com/trials/decitabine-cedazuridine-inqovi-an-oral-dna-demethylating-agent-in-subjects-with-bap1-cancer-predisposition-syndrome-and-41673https://curecurrent.com/trials/low-frequency-rtms-for-sleep-after-thoracoscopic-lung-resection-41674https://curecurrent.com/trials/a-study-of-rc48-adc-combined-with-pyrotinib-for-treatment-of-local-advanced-or-metastasis-nsclc-with-her2-mutation-41675https://curecurrent.com/trials/feasibility-of-multi-cancer-early-detection-test-in-screening-population-nqmd-cs-41676https://curecurrent.com/trials/testing-cabozantinib-in-patients-with-advanced-pancreatic-neuroendocrine-and-carcinoid-tumors-41677https://curecurrent.com/trials/study-of-212pb-pb-dotam-mam279-212pb-pb-mp0712-in-patients-with-small-cell-lung-cancer-and-other-dll3-expressing-solid-t-41678https://curecurrent.com/trials/prospective-external-control-cohort-in-patients-with-newly-diagnosed-advanced-or-metastatic-egfr-mutant-non-small-cell-l-41679https://curecurrent.com/trials/olaparib-lynparza-plus-durvalumab-imfinzi-in-egfr-mutated-adenocarcinomas-that-transform-to-small-cell-lung-cancer-sclc-41680https://curecurrent.com/trials/pulmonary-rehabilitation-in-advanced-lung-cancer-survivors-41681https://curecurrent.com/trials/primary-tumor-resection-with-egfr-tki-for-stage-iv-nsclc-41682https://curecurrent.com/trials/a-study-of-repotrectinib-versus-crizotinib-in-participants-with-locally-advanced-or-metastatic-tyrosine-kinase-inhibitor-41683https://curecurrent.com/trials/clinical-study-on-savolitinib-osimertinib-in-treatment-of-egfrm-met-locally-advanced-or-metastatic-nsclc-41684https://curecurrent.com/trials/testing-the-combination-of-xl184-cabozantinib-nivolumab-and-ipilimumab-for-poorly-differentiated-neuroendocrine-tumors-41685https://curecurrent.com/trials/a-community-health-intervention-to-improve-lung-cancer-screening-uptake-in-community-health-centers-41686https://curecurrent.com/trials/avelumab-program-rollover-study-41687https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetics-of-bnt327-in-combination-with-chemotherapy-and-other-investigational-agents-for-lun-41688https://curecurrent.com/trials/development-of-a-biologic-specimen-bank-for-the-study-of-early-markers-of-lung-cancer-among-tin-miners-in-yunnan-china-41689https://curecurrent.com/trials/a-study-of-therapeutic-drug-monitoring-based-atezolizumab-dosing-41690https://curecurrent.com/trials/low-dose-thoracic-radiotherapy-followed-by-adebrelimab-plus-chemotherapy-and-then-sequential-maintenance-therapy-with-ad-41691https://curecurrent.com/trials/phase-iii-study-of-rc148-plus-chemotherapy-versus-tislelizumab-plus-chemotherapy-as-first-line-treatment-for-non-squamou-41692https://curecurrent.com/trials/phase-i-study-of-225ac-ac-etn029-in-patients-with-advanced-dll3-expressing-solid-tumors-41693https://curecurrent.com/trials/a-study-to-assess-adverse-events-and-change-in-disease-activity-of-intravenously-iv-infused-abbv-324-in-adult-participan-41694https://curecurrent.com/trials/study-of-the-effect-of-innate-on-the-inflammatory-response-to-endotoxin-41695https://curecurrent.com/trials/testing-the-combination-of-mln4924-pevonedistat-carboplatin-and-paclitaxel-in-patients-with-advanced-non-small-cell-lung-41696https://curecurrent.com/trials/erdafitinib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-d-41697https://curecurrent.com/trials/a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-jyp0322-in-previously-untreated-ros1-positive-locally-advanced-41698https://curecurrent.com/trials/quick-start-durvalumab-following-chemoradiation-for-stage-iii-nonsmall-cell-lung-cancer-41699https://curecurrent.com/trials/study-of-izalontamab-brengitecan-bms-986507-versus-platinum-pemetrexed-for-egfr-mutated-non-small-cell-lung-cancer-after-41700https://curecurrent.com/trials/optimizing-patient-treatment-with-epa-enriched-nutrition-a-randomised-control-trial-41701https://curecurrent.com/trials/study-of-elironrasib-and-daraxonrasib-as-monotherapies-and-combination-therapy-in-participants-with-advanced-kras-g12c-m-41702https://curecurrent.com/trials/a-study-of-adagrasib-plus-pembrolizumab-plus-chemotherapy-vs-placebo-plus-pembrolizumab-plus-chemotherapy-in-participant-41703https://curecurrent.com/trials/pulmonary-hypertension-and-rv-dysfunction-in-myeloproliferative-neoplasms-41704https://curecurrent.com/trials/qualitative-study-on-detection-tx-of-nsclc-in-pts-w-a-history-of-alcohol-or-sud-41705https://curecurrent.com/trials/an-external-control-arm-study-in-non-small-cell-lung-cancer-41706https://curecurrent.com/trials/material-balance-of-14c-zorifertinib-in-healthy-adult-male-participants-in-china-41707https://curecurrent.com/trials/social-optimization-study-41708https://curecurrent.com/trials/ai-assisted-chest-ct-interpretation-across-the-lung-cancer-care-continuum-41709https://curecurrent.com/trials/a-trial-of-tarlatamab-in-patients-with-pretreated-extensive-stage-small-cell-lung-cancer-es-sclc-and-ecog-ps-2-41710https://curecurrent.com/trials/a-study-to-test-different-doses-of-obrixtamig-in-patients-with-small-cell-lung-cancer-and-other-neuroendocrine-tumours-t-41711https://curecurrent.com/trials/prospective-trial-assessing-real-world-outcomes-response-to-pembro-in-black-patients-w-nsclc-41712https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-berzosertib-m6620-vx-970-to-the-usual-treatments-carboplatin-and-gemcitabine-41713https://curecurrent.com/trials/empowering-patients-lung-cancer-screening-uptake-empower-lcs-call-41714https://curecurrent.com/trials/bms-986489-atigotatug-nivolumab-vs-durvalumab-in-limited-stage-small-cell-lung-cancer-tigos-ls-41715https://curecurrent.com/trials/ulixertinib-in-treating-patients-with-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-disorders-with-mapk-path-41716https://curecurrent.com/trials/expanded-access-program-of-neladalkib-nvl-655-for-patients-with-advanced-alk-nsclc-or-other-alk-solid-tumors-41717https://curecurrent.com/trials/tailored-patient-navigation-to-improve-the-uptake-of-lung-cancer-screening-in-tribal-communities-in-western-washington-s-41718https://curecurrent.com/trials/a-study-of-7mw3711-compared-with-docetaxel-in-advanced-squamous-nsclc-after-prior-chemoimmunotherapy-41719https://curecurrent.com/trials/a-first-in-human-trial-of-blu-924-sar449336-in-advanced-solid-tumors-harboring-kras-mutations-41720https://curecurrent.com/trials/tailordose-lung-decentralized-tdm-of-taxanes-and-alk-inhibitors-using-capillary-self-sampling-41721https://curecurrent.com/trials/erlotinib-and-docetaxel-in-second-line-of-treatment-in-patients-with-non-small-cell-lung-cancer-41722https://curecurrent.com/trials/niraparib-in-combination-with-osimertinib-in-egfr-mutated-advanced-lung-cancer-41723https://curecurrent.com/trials/safety-and-efficacy-study-of-gen1046-as-a-single-agent-or-in-combination-with-pembrolizumab-for-treatment-of-recurrent-n-41724https://curecurrent.com/trials/personalized-cancer-vaccine-pcv-strategy-in-patients-with-solid-tumors-and-molecular-residual-disease-41725https://curecurrent.com/trials/a-study-comparing-mindfulness-apps-to-decrease-anxiety-in-people-with-lung-cancer-41726https://curecurrent.com/trials/perioperative-targeted-therapy-in-resectable-or-potentially-resectable-stage-iii-non-small-cell-lung-cancer-with-rare-dr-41727https://curecurrent.com/trials/pembrolizumab-every-12-weeks-versus-every-3-weeks-in-treating-patients-with-non-small-cell-lung-cancer-41728https://curecurrent.com/trials/a-study-of-bl-m07d1-in-patients-with-her2-overexpressing-or-her2-mutant-locally-advanced-or-metastatic-non-small-cell-lu-41729https://curecurrent.com/trials/5g-enabled-remote-robotic-assisted-bronchoscopy-guided-cryoablation-for-pulmonary-malignancies-41730https://curecurrent.com/trials/testing-the-addition-of-azd6738-ceralasertib-to-immunotherapy-to-increase-time-without-cancer-for-patients-with-non-smal-41731https://curecurrent.com/trials/study-of-trilaciclib-and-lurbinectidin-41732https://curecurrent.com/trials/the-effect-of-immersive-virtual-reality-and-relaxing-videos-on-lung-cancer-patients-41733https://curecurrent.com/trials/ai-personalized-discharge-education-for-patients-after-lung-cancer-surgery-41734https://curecurrent.com/trials/reminder-messages-for-lung-cancer-screening-41735https://curecurrent.com/trials/development-and-analysis-of-a-stool-bank-for-cancer-patients-41736https://curecurrent.com/trials/nbtxr3-with-radiation-therapy-alone-for-locally-advanced-non-small-cell-lung-cancer-41737https://curecurrent.com/trials/pifenidone-prophylactic-therapy-for-radiation-lung-injury-in-patients-who-have-previously-received-immune-checkpoint-inh-41738https://curecurrent.com/trials/a-study-of-intismeran-autogene-v940-plus-pembrolizumab-mk-3475-versus-placebo-plus-pembrolizumab-in-participants-with-no-41739https://curecurrent.com/trials/testing-crizotinib-as-a-potential-targeted-treatment-in-cancers-with-ros1-genetic-changes-match-subprotocol-g-41740https://curecurrent.com/trials/predictive-biomarkers-for-pd-1-inhibitor-response-in-squamous-cell-carcinoma-41741https://curecurrent.com/trials/study-of-atezolizumab-plus-carboplatin-and-etoposide-with-or-without-tiragolumab-in-participants-with-untreated-extensiv-41742https://curecurrent.com/trials/a-study-of-bl-b01d1-combined-with-glecirasib-in-patients-with-kras-g12c-mutated-locally-advanced-or-metastatic-non-small-41743https://curecurrent.com/trials/a-global-phase-iii-study-of-rilvegostomig-or-pembrolizumab-plus-chemotherapy-for-first-line-treatment-of-locally-advance-41744https://curecurrent.com/trials/nivolumab-and-ipilimumab-with-or-without-local-consolidation-therapy-in-treating-patients-with-stage-iv-non-small-cell-l-41745https://curecurrent.com/trials/study-of-bpi-572270-in-patients-with-advanced-solid-tumors-harboring-specific-mutations-in-ras-41746https://curecurrent.com/trials/autoimmune-intervention-mastery-course-study-41747https://curecurrent.com/trials/donor-lymphocyte-infusion-after-allogeneic-hematopoietic-cell-transplantation-for-high-risk-hematologic-malignancies-41748https://curecurrent.com/trials/aurora-kinase-inhibitor-ly3295668-in-combination-with-osimertinib-for-the-treatment-of-advanced-or-metastatic-egfr-mutan-41749https://curecurrent.com/trials/a-study-of-asp388b-given-by-itself-and-with-standard-therapies-in-participants-with-solid-tumors-41750https://curecurrent.com/trials/clinical-study-of-ivonescimab-for-first-line-treatment-of-metastatic-nsclc-patients-with-high-pd-l1-41751https://curecurrent.com/trials/a-study-of-navlimetostat-bms-986504-alone-or-in-combination-with-izalontamab-brengitecan-in-participants-with-pre-treate-41752https://curecurrent.com/trials/evaluation-of-a-pneumotachograph-spi-for-the-production-of-pet-and-ct-acquisitions-synchronized-with-breath-for-the-asse-41753https://curecurrent.com/trials/20-fr-versus-24-fr-chest-drains-after-uniportal-vats-lobectomy-for-nsclc-41754https://curecurrent.com/trials/short-and-mid-term-therapeutic-prognostic-and-societal-impact-of-implementing-intraoperative-assessment-of-pulmonary-res-41755https://curecurrent.com/trials/aqua07-in-patients-with-alk-positive-non-small-cell-lung-cancer-41756https://curecurrent.com/trials/osimertinib-surgery-and-radiation-therapy-in-treating-patients-with-stage-iiib-or-iv-non-small-cell-lung-cancer-with-egf-41757https://curecurrent.com/trials/vismodegib-and-atezolizumab-for-the-treatment-of-recurrent-or-metastatic-non-small-cell-lung-cancer-41758https://curecurrent.com/trials/analyzing-clinical-outcomes-and-genomic-data-of-american-indian-patient-population-41759https://curecurrent.com/trials/a-study-of-gi-108-an-anti-cd73-igg4-fc-il-2v-bispecific-fusion-protein-as-monotherapy-in-patients-with-advanced-or-metas-41760https://curecurrent.com/trials/local-ablation-plus-systemic-therapy-for-metachronous-liver-and-or-lung-oligometastases-from-nasopharyngeal-carcinoma-41761https://curecurrent.com/trials/bl-m14d1-plus-atezolizumab-vs-standard-of-care-in-first-line-extensive-stage-small-cell-lung-cancer-brendell-lung01-41762https://curecurrent.com/trials/a-study-of-lurbinectedin-in-combination-with-durvalumab-for-the-treatment-of-participants-with-es-sclc-41763https://curecurrent.com/trials/spsipb-vs-sapb-for-thoracoscopic-surgery-41764https://curecurrent.com/trials/testing-lutetium-lu-177-dotatate-in-patients-with-somatostatin-receptor-positive-advanced-bronchial-neuroendocrine-tumor-41765https://curecurrent.com/trials/precision-prevention-strategy-to-increase-uptake-and-engagement-in-lung-cancer-screening-and-smoking-cessation-treatment-41766https://curecurrent.com/trials/coformulation-of-pembrolizumab-vibostolimab-mk-7684a-versus-pembrolizumab-mk-3475-monotherapy-for-programmed-cell-death-41767https://curecurrent.com/trials/intermittent-erector-spinae-plane-block-via-subcutaneous-port-for-cancer-pain-41768https://curecurrent.com/trials/a-study-evaluating-a-new-radiation-treatment-workflow-ngds-41769https://curecurrent.com/trials/a-phase-ii-study-of-hs-20093-injection-combined-with-adebrelimab-versus-hs-20093-injection-in-previously-treated-patient-41770https://curecurrent.com/trials/study-of-rmc-5127-in-patients-with-advanced-kras-g12v-mutant-solid-tumors-41771https://curecurrent.com/trials/rmt-in-combination-with-durvalumab-chemo-in-untreated-adenocarcinoma-nsclc-a-randomized-double-blind-phase-ii-trial-41772https://curecurrent.com/trials/study-of-safety-and-efficacy-of-ceritinib-in-combination-with-nivolumab-in-patients-with-alk-positive-non-small-cell-lun-41773https://curecurrent.com/trials/a-study-to-learn-about-patients-with-non-small-cell-lung-cancer-nsclc-who-took-lorlatinib-as-their-first-treatment-41774https://curecurrent.com/trials/a-restorative-justice-based-lung-cancer-screening-decision-making-support-intervention-tailored-for-black-individuals-to-41775https://curecurrent.com/trials/construction-and-application-research-of-a-multidisciplinary-combined-exercise-management-program-for-elderly-lung-cance-41776https://curecurrent.com/trials/phase-3-trial-of-tarlatamab-sc-vs-iv-in-extensive-stage-small-cell-lung-cancer-after-platinum-based-first-line-chemother-41777https://curecurrent.com/trials/metabolic-response-to-food-in-lung-cancer-41778https://curecurrent.com/trials/a-phase-1-study-of-gnr-051-in-subjects-with-advanced-malignancies-41779https://curecurrent.com/trials/low-dose-reduced-frequency-nivolumab-for-the-treatment-of-unresectable-or-metastatic-cancer-afford-io-trial-41780https://curecurrent.com/trials/identification-of-changes-in-cancer-related-fatigue-and-physical-activity-and-their-association-in-patients-with-inopera-41781https://curecurrent.com/trials/pemetrexed-cisplatin-and-vitamin-b12-in-treating-patients-with-mesothelioma-of-the-chest-that-cannot-be-removed-by-surge-41782https://curecurrent.com/trials/an-app-to-identify-radiation-pneumonitis-a-pre-study-in-healthy-volunteers-41783https://curecurrent.com/trials/metabolic-biomarkers-predicting-response-to-neoadjuvant-immunotherapy-in-non-small-cell-lung-cancer-41784https://curecurrent.com/trials/mindfulness-oriented-respiratory-distress-symptom-intervention-for-lung-cancer-41785https://curecurrent.com/trials/a-study-to-compare-setidegrasib-asp3082-with-docetaxel-in-people-with-non-small-cell-lung-cancer-with-a-kras-g12d-mutati-41786https://curecurrent.com/trials/prospective-study-of-intensity-modulated-proton-therapy-impt-for-small-cell-lung-cancer-41787https://curecurrent.com/trials/a-phase-3-trial-in-advanced-epithelioid-mesothelioma-41788https://curecurrent.com/trials/testing-the-combination-of-an-anti-cancer-drug-iadademstat-with-other-anti-cancer-drugs-atezolizumab-or-durvalumab-at-im-41789https://curecurrent.com/trials/a-study-of-yl201-in-combination-with-other-anti-cancer-therapies-in-patients-with-advanced-solid-tumors-41790https://curecurrent.com/trials/tocilizumab-ipilimumab-and-nivolumab-for-the-treatment-of-advanced-melanoma-non-small-cell-lung-cancer-or-urothelial-car-41791https://curecurrent.com/trials/a-phase-1-2-study-of-bgb-b2033-alone-or-in-combination-with-tislelizumab-with-or-without-bevacizumab-in-participants-wit-41792https://curecurrent.com/trials/cardiovascular-injury-and-cardiac-fitness-in-locally-advanced-non-small-cell-lung-cancer-patients-receiving-model-based-41793https://curecurrent.com/trials/proton-beam-radiation-therapy-after-treatment-for-resected-n2-non-small-cell-lung-cancer-41794https://curecurrent.com/trials/study-of-pembrolizumab-plus-chemotherapy-with-lenvatinib-for-malignant-pleural-mesothelioma-41795https://curecurrent.com/trials/goals-of-care-conversations-study-41796https://curecurrent.com/trials/telaglenastat-hydrochloride-and-osimertinib-in-treating-patients-with-egfr-mutated-stage-iv-non-small-cell-lung-cancer-41797https://curecurrent.com/trials/study-of-ism6331-in-participants-with-advanced-metastatic-mesothelioma-or-other-advanced-solid-tumors-41798https://curecurrent.com/trials/statins-to-prevent-cancer-associated-blood-clots-41799https://curecurrent.com/trials/eras-compliance-and-nutritional-outcomes-after-lung-cancer-surgery-41800https://curecurrent.com/trials/accurate-planning-and-guidance-of-bronchoscopy-for-lung-cancer-management-41801https://curecurrent.com/trials/evaluating-bl-m14d1-in-subjects-with-locally-advanced-or-metastatic-small-cell-lung-cancer-and-neuroendocrine-tumors-41802https://curecurrent.com/trials/image-guided-intensity-modulated-photon-or-proton-beam-radiation-therapy-in-treating-patients-with-stage-ii-iiib-non-sma-41803https://curecurrent.com/trials/phase-1-2-trial-of-s241656-in-selected-ras-mapk-mutation-positive-malignancies-41804https://curecurrent.com/trials/a-study-to-evaluate-arv-806-in-adults-with-advanced-cancer-that-has-the-kras-g12d-mutation-41805https://curecurrent.com/trials/mechanism-and-immune-function-analysis-of-sars-cov-2-infection-in-hematologic-tumors-41806https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-divarasib-versus-sotorasib-or-adagrasib-in-participants-with-previously-tr-41807https://curecurrent.com/trials/sib-accelerated-hyperfractionated-rt-for-high-proliferation-nsclc-41808https://curecurrent.com/trials/a-study-of-tepotinib-and-ivonescimab-in-people-with-non-small-cell-lung-cancer-41809https://curecurrent.com/trials/a-study-of-dc05f01-in-chinese-patients-with-recurrent-refractory-ovarian-cancer-and-other-advanced-solid-tumors-41810https://curecurrent.com/trials/thio-sequenced-with-cemiplimab-in-advanced-nsclc-41811https://curecurrent.com/trials/study-of-tub-040-in-participants-with-unresectable-or-metastatic-nonsquamous-non-small-cell-lung-cancer-41812https://curecurrent.com/trials/adjuvant-therapy-omission-for-resected-nsclc-patients-with-longitudinal-undetectable-mrd-41813https://curecurrent.com/trials/consolidative-stereotactic-radiotherapy-for-oligo-residual-advanced-egfr-mutant-nsclc-after-first-line-third-generation-41814https://curecurrent.com/trials/phase-2-trial-of-adagrasib-monotherapy-and-in-combination-with-pembrolizumab-and-a-phase-3-trial-of-adagrasib-in-combina-41815https://curecurrent.com/trials/quaratusugene-ozeplasmid-reqorsa-and-osimertinib-in-patients-with-advanced-lung-cancer-who-progressed-on-osimertinib-41816https://curecurrent.com/trials/a-study-of-regn5093-in-adult-patients-with-mesenchymal-epithelial-transition-factor-met-altered-advanced-non-small-cell-41817https://curecurrent.com/trials/a-study-evaluating-hs-10370-plus-platinum-based-doublet-chemotherapy-with-or-without-adebrelimab-vs-tislelizumab-plus-ch-41818https://curecurrent.com/trials/gemcitabine-carboplatin-and-lenalidomide-for-treatment-of-advanced-metastatic-urothelial-cancer-and-other-solid-tumors-41819https://curecurrent.com/trials/effectiveness-of-chat-based-mobile-application-for-consultation-zalo-in-improving-compliance-with-follow-up-tests-after-41820https://curecurrent.com/trials/a-study-of-bio-300-and-thoracic-radiation-therapy-in-people-with-non-small-cell-lung-cancer-and-interstitial-lung-diseas-41821https://curecurrent.com/trials/efficiency-of-contemporary-off-line-adaptive-radiotherapy-for-lung-cancer-41822https://curecurrent.com/trials/clinical-trial-of-cd40l-augmented-til-for-patients-with-egfr-alk-ros1-or-her2-driven-nsclc-41823https://curecurrent.com/trials/re104-safety-and-efficacy-study-in-adjustment-disorder-in-cancer-and-other-medical-illnesses-41824https://curecurrent.com/trials/video-assisted-thoracoscopic-surgery-combined-with-radiofrequency-ablation-versus-vats-alone-for-multiple-primary-lung-c-41825https://curecurrent.com/trials/pharmacokinetic-study-of-pembrolizumab-and-its-impact-on-immunity-and-the-tumor-microenvironment-which-may-explain-the-e-41826https://curecurrent.com/trials/multimodal-ai-predicts-high-risk-pathology-in-lung-cancer-associated-with-cystic-airspaces-41827https://curecurrent.com/trials/paclitaxel-polymeric-micelles-plus-ivonescimab-in-recurrent-or-refractory-sclc-41828https://curecurrent.com/trials/osimertinib-and-tegavivint-as-first-line-therapy-for-the-treatment-of-metastatic-egfr-mutant-non-small-cell-lung-cancer-41829https://curecurrent.com/trials/prospective-study-on-radiation-induced-cardiotoxicity-assessed-by-pet-ct-for-locally-advanced-non-small-cell-lung-cancer-41830https://curecurrent.com/trials/effects-of-infusion-timing-on-treatment-response-in-solid-tumors-41831https://curecurrent.com/trials/study-of-trastuzumab-deruxtecan-pembrolizumab-and-platinum-based-chemotherapy-in-first-line-her2-overexpressing-non-smal-41832https://curecurrent.com/trials/using-urine-samples-to-identify-lung-cancer-41833https://curecurrent.com/trials/dareon-9-a-study-to-test-how-well-different-doses-of-bi-764532-are-tolerated-by-people-with-small-cell-lung-cancer-when-41834https://curecurrent.com/trials/a-study-evaluating-the-safety-efficacy-and-pharmacokinetics-pk-of-evolve104-in-participants-with-advanced-urothelial-and-41835https://curecurrent.com/trials/sintilimab-combined-with-tafolecimab-and-chemotherapy-as-first-line-treatment-for-extensive-stage-small-cell-lung-cancer-41836https://curecurrent.com/trials/tt-4-and-tt-10-as-single-agents-and-in-combination-in-subjects-with-advanced-selected-solid-tumors-and-pleural-mesotheli-41837https://curecurrent.com/trials/photoimmunotherapy-with-asp-1929-and-cemiplimab-for-the-treatment-of-refractory-inoperable-and-metastatic-stage-iiib-iv-41838https://curecurrent.com/trials/hearts-trial-for-thoracic-cancers-41839https://curecurrent.com/trials/a-phase-iii-study-of-yl201-in-relapsed-small-cell-lung-cancer-taishan-302-41840https://curecurrent.com/trials/toripalimab-plus-sacituzumab-tirumotecan-as-neoadjuvant-therapy-for-resectable-nsclc-41841https://curecurrent.com/trials/infectious-complications-after-esophagectomy-41842https://curecurrent.com/trials/safety-of-rad301-in-healthy-human-volunteers-and-patients-with-pancreatic-cancer-or-other-solid-tumors-41843https://curecurrent.com/trials/a-study-of-zl-1310-versus-investigator-s-choice-of-therapy-in-participants-with-relapsed-small-cell-lung-cancer-dllevate-41844https://curecurrent.com/trials/biomarkers-of-resiliency-in-childhood-cancer-surgery-41845https://curecurrent.com/trials/study-to-evaluate-adverse-events-optimal-dose-and-change-in-disease-activity-with-livmoniplimab-in-combination-with-budi-41846https://curecurrent.com/trials/an-evaluation-of-dose-escalation-for-intrathoracic-tumours-41847https://curecurrent.com/trials/atezolizumab-and-bevacizumab-in-treating-patients-with-rare-solid-tumors-41848https://curecurrent.com/trials/c-raven-ldct-lung-cancer-screening-intervention-41849https://curecurrent.com/trials/ipilimumab-and-nivolumab-in-combination-with-radiation-therapy-in-treating-patients-with-stage-2-3-non-small-lung-cancer-41850https://curecurrent.com/trials/nut-project-nutritional-support-in-thoracic-oncology-41851https://curecurrent.com/trials/comparison-of-biportal-versus-multiportal-robotic-approaches-for-pulmonary-resection-in-nsclc-41852https://curecurrent.com/trials/an-expanded-access-program-to-provide-divarasib-to-participants-with-previously-treated-kras-g12c-positive-advanced-or-m-41853https://curecurrent.com/trials/gi-101-gi-101a-as-a-single-agent-or-in-combination-with-pembrolizumab-or-lenvatinib-in-advanced-solid-tumors-41854https://curecurrent.com/trials/tuvusertib-m1774-in-combination-with-cemiplimab-in-participants-with-non-squamous-nsclc-ddriver-nsclc-322-41855https://curecurrent.com/trials/testing-if-high-dose-radiation-only-to-the-sites-of-brain-cancer-compared-to-whole-brain-radiation-that-avoids-the-hippo-41856https://curecurrent.com/trials/indocyanine-green-icg-guided-tumor-resection-41857https://curecurrent.com/trials/safety-preliminary-effectiveness-of-bnt327-an-investigational-therapy-for-patients-with-small-cell-lung-cancer-in-combin-41858https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-bms-986525-alone-and-in-combination-therapy-in-participants-with-relaps-41859https://curecurrent.com/trials/iadademstat-sbrt-with-atezo-in-es-sclc-41860https://curecurrent.com/trials/the-rise-in-robotic-atypical-segmentectomies-41861https://curecurrent.com/trials/adaptive-sbrt-plus-chemoimmunotherapy-for-es-sclc-41862https://curecurrent.com/trials/fih-study-to-investigate-safety-pk-and-efficacy-of-the-napi2b-adc-tub-040-in-patients-with-proc-or-r-r-adenocarcinoma-ns-41863https://curecurrent.com/trials/cranial-radiotherapy-plus-chemoimmunotherapy-in-untreated-driver-mutation-negative-nsclc-with-active-brain-metastasis-41864https://curecurrent.com/trials/stereotactic-radiosurgery-for-the-treatment-of-patients-with-small-cell-lung-cancer-brain-metastasis-41865https://curecurrent.com/trials/srt-combined-with-envafolimab-and-endostar-in-the-first-line-treatment-of-advanced-nsclc-41866https://curecurrent.com/trials/safety-pk-and-efficacy-of-ai-061-in-advanced-solid-tumors-41867https://curecurrent.com/trials/lung-cancer-robotic-comparative-study-41868https://curecurrent.com/trials/sp-thoracic-ide-study-41869https://curecurrent.com/trials/double-blind-placebo-controlled-controlled-study-of-adjuvant-medi4736-in-completely-resected-nsclc-41870https://curecurrent.com/trials/sacituzumab-tirumotecan-mk-2870-versus-pemetrexed-and-carboplatin-combination-therapy-in-participants-with-epidermal-gro-41871https://curecurrent.com/trials/covici-surv-covid-19-vaccination-around-ici-start-and-survival-41872https://curecurrent.com/trials/a-multicenter-cohort-study-of-ai-based-methods-for-pulmonary-nodule-diagnosis-and-follow-up-41873https://curecurrent.com/trials/the-efficacy-and-safety-of-narlumosbart-in-combination-with-stereotactic-body-radiation-therapy-to-improve-the-efficacy-41874https://curecurrent.com/trials/a-study-of-nivolumab-and-chemotherapy-followed-by-surgery-for-mesothelioma-41875https://curecurrent.com/trials/cd70-targeted-car-t-therapy-in-cd70-positive-advanced-solid-tumors-41876https://curecurrent.com/trials/early-feeding-and-mobilization-in-thoracic-surgery-41877https://curecurrent.com/trials/a-multi-centre-chart-review-study-of-stage-i-iii-non-small-cell-lung-cancer-in-china-41878https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-bms-986489-atigotatug-nivolumab-fixed-dose-combination-in-combination-with-41879https://curecurrent.com/trials/dose-escalation-study-of-a-pd1-lag3-bispecific-antibody-in-patients-with-advanced-and-or-metastatic-solid-tumors-41880https://curecurrent.com/trials/study-of-pembrolizumab-vibostolimab-coformulation-mk-7684a-in-combination-with-chemotherapy-versus-pembrolizumab-plus-ch-41881https://curecurrent.com/trials/study-of-sacituzumab-govitecan-combinations-in-first-line-treatment-of-participants-with-advanced-or-metastatic-non-smal-41882https://curecurrent.com/trials/evaluate-the-safety-tolerability-and-preliminary-efficacy-of-evm14-in-combination-with-ivonescimab-in-sq-nsclc-patients-41883https://curecurrent.com/trials/durvalumab-consolidation-after-chemoradiation-therapy-for-limited-stage-sclc-in-china-41884https://curecurrent.com/trials/a-study-to-evaluate-patient-reported-satisfaction-effectiveness-and-safety-of-atezolizumab-in-participants-treated-in-ro-41885https://curecurrent.com/trials/osimertinib-alone-or-with-chemotherapy-for-egfr-mutant-lung-cancers-41886https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-medi5752-in-combination-with-stereotactic-radiotherapy-in-patients-with-meta-41887https://curecurrent.com/trials/a-study-of-adebrelimab-combined-with-apatinib-mesylate-and-chemotherapy-for-neoadjuvant-therapy-and-biomarker-analysis-i-41888https://curecurrent.com/trials/phi-ii-study-of-amivantamab-and-tepotinib-combo-in-met-altered-non-small-cell-lung-cancer-41889https://curecurrent.com/trials/adjuvant-chemotherapy-in-patients-with-intermediate-or-high-risk-stage-i-or-stage-iia-non-squamous-non-small-cell-lung-c-41890https://curecurrent.com/trials/azd9291-versus-placebo-in-patients-with-stage-ib-iiia-non-small-cell-lung-carcinoma-following-complete-tumour-resection-41891https://curecurrent.com/trials/a-study-to-evaluate-dji136-a-dll3-targeted-car-t-therapy-41892https://curecurrent.com/trials/a-phase-ii-study-of-tislelizumab-plus-anlotinib-consolidation-after-chemoradiotherapy-in-ls-sclc-41893https://curecurrent.com/trials/gut-microbiome-in-patients-with-lung-and-melanoma-cancer-and-intestinal-microbiota-in-gynecologic-cancers-41894https://curecurrent.com/trials/quaratusugene-ozeplasmid-reqorsa-and-atezolizumab-maintenance-therapy-in-es-sclc-patients-41895https://curecurrent.com/trials/lung-cancer-screening-implementation-project-in-the-brazilian-public-health-care-system-lusip-41896https://curecurrent.com/trials/establishing-feasibility-of-transbronchial-cryoablation-with-an-in-development-cryoprobe-an-ex-vivo-human-lung-model-41897https://curecurrent.com/trials/safety-and-diagnostic-performance-of-111in-tjd-31-spect-imaging-in-patients-with-solid-tumors-41898https://curecurrent.com/trials/a-study-of-sotorasib-in-people-with-non-small-cell-lung-cancer-41899https://curecurrent.com/trials/identification-and-validation-of-blood-based-biomarkers-for-early-detection-of-asymptomatic-lung-cancer-in-high-risk-hea-41900https://curecurrent.com/trials/study-of-durvalumab-olaparib-or-durvalumab-after-treatment-with-durvalumab-and-chemotherapy-in-patients-with-lung-cancer-41901https://curecurrent.com/trials/evaluation-of-cemiplimab-in-combination-with-platinum-doublet-chemotherapy-in-first-line-1l-treatment-of-advanced-non-sm-41902https://curecurrent.com/trials/comparison-of-perioperative-immunotherapy-adjuvant-immunotherapy-or-neoadjuvant-immunotherapy-for-resectable-stage-ii-ii-41903https://curecurrent.com/trials/usefulness-of-thromboelastography-as-a-predictor-of-prognosis-in-patients-undergoing-surgery-for-glial-tumors-and-of-the-41904https://curecurrent.com/trials/study-of-efficacy-and-safety-of-jdq443-single-agent-as-first-line-treatment-for-patients-with-locally-advanced-or-metast-41905https://curecurrent.com/trials/a-study-of-multiple-therapies-in-biomarker-selected-participants-with-resectable-stages-ib-iii-non-small-cell-lung-cance-41906https://curecurrent.com/trials/lazertinib-tepotinib-for-egfr-mutant-nsclc-in-met-overexpressed-or-amplified-who-progressed-after-lazertinib-treatment-41907https://curecurrent.com/trials/increasing-equity-in-lung-cancer-screening-41908https://curecurrent.com/trials/real-time-non-invasive-localization-for-multiple-lung-nodules-41909https://curecurrent.com/trials/non-ablative-oligofractionated-radiation-therapy-before-surgical-transplantation-as-radiovaccination-41910https://curecurrent.com/trials/a-study-comparing-bl-b01d1-in-combination-with-osimertinib-versus-osimertinib-alone-in-patients-with-locally-advanced-un-41911https://curecurrent.com/trials/neoadjuvant-nivolumab-or-nivolumab-in-combination-with-ipilimumab-in-resectable-nsclc-41912https://curecurrent.com/trials/virus-associated-tumour-microenvironment-41913https://curecurrent.com/trials/biologically-guided-radiation-therapy-bgrt-and-stereotactic-body-radiation-therapy-sbrt-to-tyrosine-kinase-inhibitor-in-41914https://curecurrent.com/trials/preoperative-evaluation-of-lymph-nodes-of-cholangiocarcinoma-poelh-iii-41915https://curecurrent.com/trials/percutaneous-pulsed-electric-field-ablation-for-early-stage-nsclc-and-lung-oligometastases-a-safety-and-efficacy-study-41916https://curecurrent.com/trials/a-study-to-compare-pharmacokinetics-efficacy-safety-and-immunogenicity-of-mb12-proposed-pembrolizumab-biosimilar-to-keyt-41917https://curecurrent.com/trials/role-of-genetic-factors-in-the-development-of-lung-disease-41918https://curecurrent.com/trials/a-study-of-jzp815-oral-capsules-in-adult-participants-with-advanced-or-metastatic-solid-tumors-harboring-mitogen-activat-41919https://curecurrent.com/trials/a-study-of-kk2269-in-adult-participants-with-solid-tumors-41920https://curecurrent.com/trials/ap-l1898-capsule-in-patients-with-non-small-cell-lung-cancer-41921https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-bay-1895344-to-usual-chemotherapy-for-advanced-stage-solid-tumors-with-a-spe-41922https://curecurrent.com/trials/tiragolumab-with-atezolizumab-plus-bevacizumab-in-previously-treated-advanced-non-squamous-nsclc-41923https://curecurrent.com/trials/radiation-therapy-regimens-in-treating-patients-with-limited-stage-small-cell-lung-cancer-receiving-cisplatin-and-etopos-41924https://curecurrent.com/trials/right-ventricular-afterload-indices-in-lung-surgery-41925https://curecurrent.com/trials/clinical-trial-for-safety-and-effectiveness-evaluation-of-tarlatamab-amg757-with-etoposide-carboplatin-and-atezolizumab-41926https://curecurrent.com/trials/a-study-of-prmt5-inhibitor-bay-3713372-in-participants-with-mtap-deleted-solid-tumors-41927https://curecurrent.com/trials/a-phase-1-study-of-epi-326-in-egfr-mutant-nsclc-and-hnscc-41928https://curecurrent.com/trials/trial-of-ado-trastuzumab-emtansine-for-patients-with-her2-amplified-or-mutant-cancers-41929https://curecurrent.com/trials/intervention-to-improve-utilization-of-extended-venous-thromboembolism-prophylaxis-after-cancer-surgery-41930https://curecurrent.com/trials/a-prospective-single-center-non-randomized-interventional-study-on-the-effectiveness-and-safety-of-combined-immunotarget-41931https://curecurrent.com/trials/a-phase-iii-open-label-study-of-maintenance-lurbinectedin-in-combination-with-atezolizumab-compared-with-atezolizumab-in-41932https://curecurrent.com/trials/repotrectinib-in-ros1-positive-non-small-cell-lung-cancer-patients-with-active-brain-metastasis-41933https://curecurrent.com/trials/a-vaccine-booster-geo-cm04s1-for-the-prevention-of-covid-19-in-patients-with-chronic-lymphocytic-leukemia-41934https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-divarasib-compared-with-investigator-s-choice-of-immunotherapy-or-observa-41935https://curecurrent.com/trials/trop2-nmr-concordance-study-41936https://curecurrent.com/trials/station-4l-lymph-node-dissection-versus-no-dissection-in-clinical-stage-i-solid-nodule-type-invasive-nsclc-41937https://curecurrent.com/trials/osimertinib-with-or-without-primary-lung-tumor-resection-for-egfr-mutant-oligometastatic-non-small-cell-lung-cancer-41938https://curecurrent.com/trials/wireless-wearable-home-prehabilitation-for-older-adults-with-nsclc-41939https://curecurrent.com/trials/study-to-assess-neoadjuvant-durvalumab-d-and-platinum-based-chemotherapy-ct-followed-by-either-surgery-and-adjuvant-d-or-41940https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-mrg003-in-patients-with-egfr-positive-advanced-non-small-cell-lung-cancer-41941https://curecurrent.com/trials/safety-and-preliminary-effectiveness-of-bnt317-an-investigational-therapy-for-advanced-solid-tumors-41942https://curecurrent.com/trials/prospective-non-interventional-study-comparing-osimertinib-chemotherapy-for-egfr-mutated-nsclc-patients-41943https://curecurrent.com/trials/a-study-to-investigate-efficacy-and-safety-of-ceralasertib-plus-durvalumab-in-participants-aged-18-years-with-advanced-o-41944https://curecurrent.com/trials/using-community-health-workers-to-support-rural-care-partners-of-seriously-ill-older-veterans-41945https://curecurrent.com/trials/pemetrexed-disodium-and-cisplatin-with-or-without-cediranib-maleate-in-treating-patients-with-malignant-pleural-mesothel-41946https://curecurrent.com/trials/study-investigating-tarlatamab-amg-757-in-patients-with-metastatic-locally-advanced-small-cell-lung-cancer-sclc-and-othe-41947https://curecurrent.com/trials/study-to-allow-patients-previously-participating-in-a-novartis-sponsored-trial-to-continue-receiving-capmatinib-treatmen-41948https://curecurrent.com/trials/a-study-of-osimertinib-with-or-without-chemotherapy-versus-chemotherapy-alone-as-neoadjuvant-therapy-for-patients-with-e-41949https://curecurrent.com/trials/the-construction-and-clinical-application-of-an-integrated-perioperative-management-system-for-lung-cancer-based-on-wear-41950https://curecurrent.com/trials/synchronous-bilateral-talc-pleurodesis-41951https://curecurrent.com/trials/first-line-tarlatamab-in-combination-with-carboplatin-etoposide-and-pd-l1-inhibitor-in-subjects-with-extensive-stage-sma-41952https://curecurrent.com/trials/pembro-k-evaluation-of-pembrolizumab-therapeutic-pharmacological-monitoring-benefit-in-nsclc-41953https://curecurrent.com/trials/neoadjuvant-therapy-with-firmonertinib-combined-with-anlotinib-and-platinum-based-doublet-chemotherapy-for-resectable-eg-41954https://curecurrent.com/trials/understanding-rural-patient-and-provide-preferences-for-mobile-lung-cancer-screening-clinics-41955https://curecurrent.com/trials/the-effects-of-low-intensity-endurance-exercise-on-improving-mitochondrial-function-cell-bioelectrical-impedance-phase-a-41956https://curecurrent.com/trials/neuroendocrine-carcinomas-patient-journey-and-treatment-outcomes-in-latin-america-41957https://curecurrent.com/trials/prophylactic-anti-seizure-medication-vs-no-anti-seizure-medication-for-patients-with-primary-motor-cortex-brain-metastas-41958https://curecurrent.com/trials/a-study-of-ly4050784-in-participants-with-advanced-or-metastatic-solid-tumors-41959https://curecurrent.com/trials/real-world-study-of-icotinib-in-adjuvant-post-surgical-treatment-for-stage-ia2-high-risk-to-ib-egfr-mutant-non-small-cel-41960https://curecurrent.com/trials/phase-ib-study-of-oral-r01-monotherapy-in-advanced-solid-tumors-41961https://curecurrent.com/trials/a-study-to-investigate-safety-and-efficacy-of-osimertinib-and-amivantamab-in-participants-with-non-small-cell-lung-cance-41962https://curecurrent.com/trials/18g-ultrafine-cryoablation-needle-for-coaxial-biopsy-and-cryoablation-of-pulmonary-nodules-41963https://curecurrent.com/trials/investigating-the-combination-of-bexmarilimab-and-nivolumab-in-solid-tumours-melanoma-and-nsclc-41964https://curecurrent.com/trials/survival-improvement-in-lung-cancer-induced-by-denosumab-therapy-41965https://curecurrent.com/trials/a-study-comparing-tarlatamab-durvalumab-carboplatin-and-etoposide-versus-durvalumab-carboplatin-and-etoposide-in-first-l-41966https://curecurrent.com/trials/a-study-to-assess-adverse-events-change-in-disease-activity-and-how-intravenous-abbv-253-moves-through-the-body-in-adult-41967https://curecurrent.com/trials/a-study-of-incb099280-in-combination-with-adagrasib-in-adults-with-advanced-solid-tumors-harboring-a-krasg12c-mutation-41968https://curecurrent.com/trials/hta-of-nivats-based-on-rwe-41969https://curecurrent.com/trials/olive-oil-before-lung-cancer-surgery-to-prevent-chylothorax-41970https://curecurrent.com/trials/understanding-the-feasibility-of-a-co-designed-pre-radiotherapy-exercise-programme-a-single-arm-study-41971https://curecurrent.com/trials/molecular-analysis-of-suspected-or-high-risk-lung-cancer-to-drive-individualized-care-41972https://curecurrent.com/trials/leveraging-the-emergency-department-lead-study-41973https://curecurrent.com/trials/a-clinical-trial-on-the-efficacy-and-safety-of-tqb6411-for-injection-41974https://curecurrent.com/trials/stereotactic-radiation-for-growing-changing-brain-metastases-with-same-day-radiation-planning-and-treatment-with-margin-41975https://curecurrent.com/trials/smartphone-based-remote-symptom-monitoring-to-improve-postoperative-rehabilitation-exercise-adherence-after-video-assist-41976https://curecurrent.com/trials/study-to-confirm-efficacy-and-feasibility-of-tarlatamab-treatment-in-patients-with-extensive-stage-small-cell-lung-cance-41977https://curecurrent.com/trials/aventine-1-study-of-avzo-1418-as-a-single-agent-and-in-combination-therapy-in-patients-with-locally-advanced-or-metastat-41978https://curecurrent.com/trials/staging-strategies-and-their-association-with-prognosis-and-therapy-in-lung-cancer-with-cystic-airspaces-41979https://curecurrent.com/trials/a-phase-i-study-of-cft8919-in-patients-with-advanced-nsclc-41980https://curecurrent.com/trials/lurbinectedin-plus-paclitaxel-versus-paclitaxel-in-patients-with-previously-treated-small-cell-lung-cancer-41981https://curecurrent.com/trials/exhaled-breath-electronic-nose-for-multi-disease-risk-prescreening-41982https://curecurrent.com/trials/trametinib-and-docetaxel-in-treating-patients-with-recurrent-or-stage-iv-kras-mutation-positive-non-small-cell-lung-canc-41983https://curecurrent.com/trials/a-prospective-single-center-single-arm-single-institution-registry-that-aims-to-assess-the-safety-and-quality-of-life-be-41984https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-trc102-to-the-usual-chemotherapy-treatment-pemetrexed-cisplatin-or-carboplat-41985https://curecurrent.com/trials/prosight-a-multi-centre-interventional-study-evaluating-mced-in-asymptomatic-population-41986https://curecurrent.com/trials/the-prospective-non-randomized-case-control-study-from-real-world-lung-cancer-patients-41987https://curecurrent.com/trials/observational-study-that-will-analyse-the-spread-and-stratification-of-lung-cancer-risk-using-artificial-intelligence-41988https://curecurrent.com/trials/a-study-to-test-the-safety-tolerability-and-effect-of-zi-ma4-1-for-patients-with-locally-advanced-or-metastatic-solid-ma-41989https://curecurrent.com/trials/teachable-moment-to-opt-out-of-tobacco-interactive-voice-response-quit-line-for-veteran-active-smokers-with-lung-nodules-41990https://curecurrent.com/trials/study-of-mgy825-in-patients-with-advanced-non-small-cell-lung-cancer-41991https://curecurrent.com/trials/a-study-of-lung-cancer-screening-in-people-with-unexplained-weight-loss-41992https://curecurrent.com/trials/phase-iii-study-of-datopotamab-deruxtecan-versus-docetaxel-in-previously-treated-trop2-positive-advanced-or-metastatic-n-41993https://curecurrent.com/trials/label-free-femtosecond-laser-imaging-combined-with-the-fast-lung-artificial-intelligence-model-for-rapid-intraoperative-41994https://curecurrent.com/trials/ai-based-personalized-digital-management-for-high-risk-pulmonary-nodule-follow-up-41995https://curecurrent.com/trials/sotorasib-in-combination-with-trastuzumab-deruxtecan-for-the-treatment-of-locally-advanced-and-metastatic-non-small-cell-41996https://curecurrent.com/trials/adagrasib-in-patients-with-krasg12c-mutant-nsclc-who-are-elderly-or-have-poor-performance-status-41997https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-multiple-targeted-therapies-as-treatments-for-participants-with-non-small-41998https://curecurrent.com/trials/chemo-immunotherapy-followed-by-durvalumab-and-ceralasertib-in-treatment-na-ve-patients-with-extensive-stage-small-cell-41999https://curecurrent.com/trials/savolitinib-combine-with-durvalumab-in-egfr-wild-type-locally-advanced-or-metastatic-nsclc-42000